###begin article-title 0
###xml 0 4 0 4 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Pten</italic>
Pten (phosphatase and tensin homologue gene) haploinsufficiency promotes insulin hypersensitivity
###end article-title 0
###begin title 1
Aims/hypothesis
###end title 1
###begin p 2
###xml 448 452 448 452 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Pten</italic>
Insulin controls glucose metabolism via multiple signalling pathways, including the phosphatidylinositol 3-kinase (PI3K) pathway in muscle and adipose tissue. The protein/lipid phosphatase Pten (phosphatase and tensin homologue deleted on chromosome 10) attenuates PI3K signalling by dephosphorylating the phosphatidylinositol 3,4,5-trisphosphate generated by PI3K. The current study was aimed at investigating the effect of haploinsufficiency for Pten on insulin-stimulated glucose uptake.
###end p 2
###begin title 3
Materials and methods
###end title 3
###begin p 4
###xml 23 27 23 27 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Pten</italic>
###xml 42 46 42 46 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Pten</italic>
###xml 46 49 46 49 <sup xmlns:xlink="http://www.w3.org/1999/xlink">+/&#8722;</sup>
###xml 203 207 203 207 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Pten</italic>
###xml 207 210 207 210 <sup xmlns:xlink="http://www.w3.org/1999/xlink">+/&#8722;</sup>
###xml 51 55 <span type="species:ncbi:10090">mice</span>
###xml 211 215 <span type="species:ncbi:10090">mice</span>
Insulin sensitivity in Pten heterozygous (Pten+/-) mice was investigated in i.p. insulin challenge and glucose tolerance tests. Glucose uptake was monitored in vitro in primary cultures of myocytes from Pten+/- mice, and in vivo by positron emission tomography. The phosphorylation status of protein kinase B (PKB/Akt), a downstream signalling protein in the PI3K pathway, and glycogen synthase kinase 3beta (GSK3beta), a substrate of PKB/Akt, was determined by western immunoblotting.
###end p 4
###begin title 5
Results
###end title 5
###begin p 6
###xml 58 62 58 62 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Pten</italic>
###xml 62 65 62 65 <sup xmlns:xlink="http://www.w3.org/1999/xlink">+/&#8722;</sup>
###xml 279 283 279 283 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Pten</italic>
###xml 283 286 283 286 <sup xmlns:xlink="http://www.w3.org/1999/xlink">+/&#8722;</sup>
###xml 338 342 338 342 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Pten</italic>
###xml 342 345 342 345 <sup xmlns:xlink="http://www.w3.org/1999/xlink">+/&#8722;</sup>
###xml 381 385 381 385 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Pten</italic>
###xml 385 388 385 388 <sup xmlns:xlink="http://www.w3.org/1999/xlink">+/&#8722;</sup>
###xml 465 469 462 466 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Pten</italic>
###xml 469 472 466 469 <sup xmlns:xlink="http://www.w3.org/1999/xlink">+/&#8722;</sup>
###xml 66 70 <span type="species:ncbi:10090">mice</span>
###xml 145 149 <span type="species:ncbi:10090">mice</span>
###xml 287 291 <span type="species:ncbi:10090">mice</span>
###xml 389 393 <span type="species:ncbi:10090">mice</span>
Following i.p. insulin challenge, blood glucose levels in Pten+/- mice remained depressed for up to 120 min, whereas glucose levels in wild-type mice began to recover after approximately 30 min. After glucose challenge, blood glucose returned to normal about twice as rapidly in Pten+/- mice. Enhanced glucose uptake was observed both in Pten+/- myocytes and in skeletal muscle of Pten+/- mice by PET. PKB and GSK3beta phosphorylation was enhanced and prolonged in Pten+/- myocytes.
###end p 6
###begin title 7
Conclusions/interpretation
###end title 7
###begin p 8
###xml 129 133 129 133 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Pten</italic>
###xml 227 231 227 231 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Pten</italic>
###xml 231 234 231 234 <sup xmlns:xlink="http://www.w3.org/1999/xlink">+/&#8722;</sup>
###xml 235 239 <span type="species:ncbi:10090">mice</span>
Pten is a key negative regulator of insulin-stimulated glucose uptake in vitro and in vivo. The partial reduction of Pten due to Pten haploinsufficiency is enough to elicit enhanced insulin sensitivity and glucose tolerance in Pten+/- mice.
###end p 8
###begin title 9
Keywords
###end title 9
###begin title 10
Introduction
###end title 10
###begin p 11
###xml 324 325 324 325 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="CR1">1</xref>
###xml 574 575 574 575 <sub xmlns:xlink="http://www.w3.org/1999/xlink">3</sub>
###xml 595 596 595 596 <sub xmlns:xlink="http://www.w3.org/1999/xlink">3</sub>
###xml 978 979 978 979 <sub xmlns:xlink="http://www.w3.org/1999/xlink">3</sub>
###xml 1073 1074 1073 1074 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="CR2">2</xref>
###xml 1076 1077 1076 1077 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="CR3">3</xref>
###xml 1080 1084 1080 1084 <italic xmlns:xlink="http://www.w3.org/1999/xlink">PTEN</italic>
###xml 1203 1204 1203 1204 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="CR4">4</xref>
###xml 1205 1206 1205 1206 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="CR6">6</xref>
###xml 1233 1237 1233 1237 <italic xmlns:xlink="http://www.w3.org/1999/xlink">PTEN</italic>
###xml 1331 1332 1331 1332 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="CR4">4</xref>
###xml 1333 1334 1333 1334 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="CR8">8</xref>
###xml 1189 1194 <span type="species:ncbi:9606">human</span>
Type 2 diabetes mellitus is a multifactorial disease with a complex pathophysiology that includes defects in insulin production and a failure in peripheral tissues to take up glucose in response to insulin. Signalling via phosphatidylinositol 3-kinase (PI3K) is a key pathway in the regulation of glucose uptake by insulin [1]. Activation of PI3K via insulin receptor substrate-1 causes PI3K to phosphorylate inositol-containing phospholipids at the 3'-position of the inositol ring, increasing the levels of the lipid messenger phosphatidylinositol 3,4,5-trisphosphate (PIP3), among others. PIP3 activate a phosphoinositide kinases, which in turn phosphorylate and activate protein kinase B (PKB), also known as Akt, a key effector kinase for many of the downstream metabolic effects initiated by insulin via PI3K. The phosphatase and tensin homologue (PTEN) is a phosphatase which recognises both protein and lipid substrates. As a lipid phosphatase, PTEN dephosphorylates PIP3 at the 3'-position of the inositol ring, thereby acting as an antagonist to PI3K signalling [2, 3]. PTEN was originally identified as a tumour suppressor gene, and is one of the most commonly mutated genes in human cancer [4-6]. Mutation or deletion of PTEN has been identified in many cancers including prostate, brain, breast, endometrium and skin [4-8].
###end p 11
###begin p 12
###xml 116 117 116 117 <sub xmlns:xlink="http://www.w3.org/1999/xlink">3</sub>
###xml 244 248 244 248 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Pten</italic>
###xml 533 534 533 534 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="CR9">9</xref>
###xml 535 537 535 537 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="CR11">11</xref>
###xml 735 739 735 739 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Pten</italic>
###xml 749 753 749 753 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Pten</italic>
###xml 753 756 753 756 <italic xmlns:xlink="http://www.w3.org/1999/xlink">&#8722;/&#8722;</italic>
###xml 753 756 753 756 <sup xmlns:xlink="http://www.w3.org/1999/xlink"><italic>&#8722;/&#8722;</italic></sup>
###xml 796 797 796 797 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="CR6">6</xref>
###xml 799 801 799 801 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="CR12">12</xref>
###xml 845 849 845 849 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Pten</italic>
###xml 878 882 878 882 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Pten</italic>
###xml 882 885 882 885 <sup xmlns:xlink="http://www.w3.org/1999/xlink">+/&#8722;</sup>
###xml 985 989 985 989 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Pten</italic>
###xml 1067 1068 1067 1068 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="CR6">6</xref>
###xml 1070 1072 1070 1072 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="CR12">12</xref>
###xml 1073 1075 1073 1075 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="CR14">14</xref>
###xml 1078 1082 1078 1082 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Pten</italic>
###xml 1082 1085 1082 1085 <sup xmlns:xlink="http://www.w3.org/1999/xlink">+/&#8722;</sup>
###xml 1251 1253 1251 1253 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="CR12">12</xref>
###xml 1254 1256 1254 1256 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="CR14">14</xref>
###xml 1277 1281 1277 1281 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Pten</italic>
###xml 313 317 <span type="species:ncbi:10090">mice</span>
###xml 665 670 <span type="species:ncbi:10090">mouse</span>
###xml 809 813 <span type="species:ncbi:10090">mice</span>
###xml 1061 1065 <span type="species:ncbi:10090">mice</span>
###xml 1086 1090 <span type="species:ncbi:10090">mice</span>
As many of the metabolic outcomes of insulin are achieved through recruitment of PI3K and the subsequent rise in PIP3 levels, PTEN may have a critical role in modulating sensitivity to insulin-stimulated glucose uptake. Recent studies in which Pten was ablated specifically in liver, adipose tissue and muscle in mice by Cre recombinase-based strategies have shown a role for Pten in the regulation of insulin sensitivity in those organs, and highlighted the contributions of those organs to glucose homeostasis of the whole animal [9-11]. However, the effect of global reduction of Pten levels on glucose uptake and metabolism has not yet been shown in an in vivo mouse model. Unfortunately, experimental genetic inactivation of both Pten alleles (Pten-/-) results in early embryonic lethality [6, 12]. Thus mice harbouring inactivation of one Pten allele (haploinsufficiency, Pten+/-) are an important experimental model for studying the role of Pten in vivo. Haploinsufficiency for Pten has important consequences for cell proliferation and tumorigenesis in mice [6, 12-14]. Pten+/- mice exhibit defective apoptosis in T cells, B cells and macrophages and spontaneous neoplasms in various tissues including prostate, liver, endometrium and others [12-14]. Here we show that Pten haploinsufficiency results in insulin hypersensitivity and enhanced insulin-mediated glucose uptake.
###end p 12
###begin title 13
Materials and methods
###end title 13
###begin p 14
###xml 0 20 0 20 <bold xmlns:xlink="http://www.w3.org/1999/xlink">Experimental animals</bold>
###xml 132 136 132 136 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Pten</italic>
###xml 136 139 136 139 <sup xmlns:xlink="http://www.w3.org/1999/xlink">+/&#8722;</sup>
###xml 175 177 175 177 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="CR12">12</xref>
###xml 312 314 312 314 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="CR12">12</xref>
###xml 140 144 <span type="species:ncbi:10090">mice</span>
###xml 186 190 <span type="species:ncbi:10090">mice</span>
###xml 220 224 <span type="species:ncbi:10090">mice</span>
###xml 277 281 <span type="species:ncbi:10090">mice</span>
Experimental animals All laboratory animals were cared for and used according to guidelines of the Canadian Council on Animal Care. Pten+/- mice were generated by R. Parsons [12]. These mice were backcrossed with C57BL6 mice for more than ten generations. The genotypes of the mice were determined as described [12].
###end p 14
###begin p 15
###xml 0 27 0 27 <bold xmlns:xlink="http://www.w3.org/1999/xlink">Blood glucose determination</bold>
###xml 254 258 <span type="species:ncbi:10090">mice</span>
###xml 477 481 <span type="species:ncbi:10090">mice</span>
Blood glucose determination For determination of blood glucose levels, glucose levels in blood samples taken from tail vein were determined using a One Touch Ultra blood glucose monitor (LifeScan Inc., Milpitas, CA, USA). For the glucose tolerance test, mice were fasted overnight (15 h) prior to i.p. injection of glucose (2 mg/g body weight). Blood glucose levels were then determined at the indicated time-points following glucose injection. For the insulin challenge test, mice were fasted for 15 h prior to i.p. injection of 0.6 mU insulin/g body weight. Blood glucose levels were then determined at the indicated time-points following insulin injection.
###end p 15
###begin p 16
###xml 0 34 0 34 <bold xmlns:xlink="http://www.w3.org/1999/xlink">Determination of insulin in plasma</bold>
###xml 349 350 348 349 <italic xmlns:xlink="http://www.w3.org/1999/xlink">g</italic>
###xml 35 39 <span type="species:ncbi:10090">Mice</span>
###xml 178 182 <span type="species:ncbi:10090">mice</span>
Determination of insulin in plasma Mice were fasted for 15 h, then approximately 100 mul of blood was collected from the tail vein using pipette tips precoated with heparin. The mice were then injected i.p. with 2 mg glucose/g body weight, and a second blood sample was obtained 15 min following injection. The blood samples were centrifuged at 805 g in a table-top centrifuge, and insulin in the plasma fraction was determined using an insulin ELISA system (ALPCO Diagnostics, Salem, NH, USA) according to the manufacturer's instructions.
###end p 16
###begin p 17
###xml 0 69 0 69 <bold xmlns:xlink="http://www.w3.org/1999/xlink">Isolation of pancreatic islets and glucose-stimulated insulin release</bold>
###xml 128 130 128 130 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="CR15">15</xref>
###xml 109 113 <span type="species:ncbi:10090">mice</span>
###xml 154 158 <span type="species:ncbi:10090">mice</span>
Isolation of pancreatic islets and glucose-stimulated insulin release Islets were isolated from pancreata of mice as described [15]. Pancreata from three mice were pooled. After 24 h in culture, islets were preincubated in Krebs-Ringer bicarbonate buffer plus 0.1% BSA (KRBB-BSA) and 1.67 mmol/l glucose. The islet cells were incubated for 1 h in 1 ml KRBB-BSA containing the desired concentration of glucose (1.67 or 16.7 mmol/l). The incubation medium was then collected, and centrifuged and the supernatant fractions were used for assay of insulin content by ELISA. Total extractable insulin in islets was determined by adding 0.5 ml lysis buffer (1 mol/l acetic acid with 0.1% BSA) to the islet pellet. Cell debris was pelleted by centrifugation, and the supernatant fraction was used for insulin assay.
###end p 17
###begin p 18
###xml 0 53 0 53 <bold xmlns:xlink="http://www.w3.org/1999/xlink">Fluorescent immunohistochemistry of pancreatic islets</bold>
###xml 94 96 94 96 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="CR16">16</xref>
###xml 128 132 128 132 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Pten</italic>
###xml 132 135 132 135 <sup xmlns:xlink="http://www.w3.org/1999/xlink">+/&#8722;</sup>
###xml 136 140 <span type="species:ncbi:10090">mice</span>
###xml 237 247 <span type="species:ncbi:10141">guinea-pig</span>
###xml 322 328 <span type="species:ncbi:9986">rabbit</span>
###xml 435 439 <span type="species:ncbi:9925">goat</span>
###xml 445 455 <span type="species:ncbi:10141">guinea-pig</span>
###xml 541 547 <span type="species:ncbi:9793">donkey</span>
###xml 553 559 <span type="species:ncbi:9986">rabbit</span>
Fluorescent immunohistochemistry of pancreatic islets Immunocytochemistry has been described [16]. Pancreata from wild-type and Pten+/- mice were embedded in paraffin. Five-micron sections were incubated for 1 h at room temperature with guinea-pig anti-insulin antibody (1:100 dilution; Dako, Mississagua, ON, Canada) and rabbit anti-glucagon antibody (Dako; 1:75 dilution). Sections were visualised by incubation with Alexa-Fluor 488 goat anti-guinea-pig (Invitrogen, Molecular Probes, Burlington, ON, Canada; 1:100 dilution) and Texas Red donkey anti-rabbit antibodies (Jackson ImmunoResearch Laboratories, West Grove, PA, USA; 1:100 dilution). Sections were examined by fluorescence microscopy.
###end p 18
###begin p 19
###xml 0 26 0 26 <bold xmlns:xlink="http://www.w3.org/1999/xlink">Beta cell mass calculation</bold>
###xml 409 414 <span type="species:ncbi:10090">mouse</span>
###xml 507 512 <span type="species:ncbi:10090">mouse</span>
Beta cell mass calculation Following insulin immunostaining, pancreatic sections were captured under an FITC filter using a Zeiss Axioplan 2 microscope equipped for epifluorescence and Pathvysion imaging software. The insulin immunopositive area (as a proportion of pancreatic area) was determined in at least six fields per section using Zeiss AxioVision software, performed on eight pancreatic sections per mouse. Beta cell mass was calculated as pancreatic mass times the percent beta cell area for each mouse.
###end p 19
###begin p 20
###xml 3 5 3 5 <sup xmlns:xlink="http://www.w3.org/1999/xlink">18</sup>
###xml 0 57 0 57 <bold xmlns:xlink="http://www.w3.org/1999/xlink">2-[<sup>18</sup>F]fluoro-2-deoxyglucose uptake and microPET scanning</bold>
###xml 210 212 210 212 <sup xmlns:xlink="http://www.w3.org/1999/xlink">18</sup>
###xml 237 239 237 239 <sup xmlns:xlink="http://www.w3.org/1999/xlink">18</sup>
###xml 304 306 304 306 <sup xmlns:xlink="http://www.w3.org/1999/xlink">18</sup>
###xml 487 489 487 489 <sup xmlns:xlink="http://www.w3.org/1999/xlink">68</sup>
###xml 518 522 518 522 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Pten</italic>
###xml 522 525 522 525 <sup xmlns:xlink="http://www.w3.org/1999/xlink">+/&#8722;</sup>
###xml 604 606 604 606 <sup xmlns:xlink="http://www.w3.org/1999/xlink">18</sup>
###xml 812 814 812 814 <sup xmlns:xlink="http://www.w3.org/1999/xlink">18</sup>
###xml 913 915 913 915 <sup xmlns:xlink="http://www.w3.org/1999/xlink">18</sup>
###xml 945 947 945 947 <sup xmlns:xlink="http://www.w3.org/1999/xlink">18</sup>
###xml 58 62 <span type="species:ncbi:10090">Mice</span>
###xml 183 187 <span type="species:ncbi:10090">mice</span>
###xml 526 530 <span type="species:ncbi:10090">mice</span>
###xml 801 806 <span type="species:ncbi:10090">mouse</span>
###xml 932 937 <span type="species:ncbi:10090">mouse</span>
2-[18F]fluoro-2-deoxyglucose uptake and microPET scanning Mice were fasted for 15 h prior to i.p. injection with 0.6 mU insulin/g body weight. Twenty minutes after insulin injection, mice were injected with 2-[18F]fluoro-2-deoxyglucose (18FDG) (4.1 MBq) via the tail vein, and whole-body distribution of 18FDG was monitored by positron emission tomography (PET) using a microPET R4 tomograph (Concorde Microsystems, Knoxville, TN, USA). The image data were attenuation-corrected using a 68Ge rod source. Wild-type and Pten+/- mice were positioned side-by-side and scanned simultaneously for 60 min after 18FDG injection. Data were analysed using the manufacturer's software, ASIPro VM 5.0.1.0. For data analysis, regions of interest (ROIs) were specified in the coronal section of a hindlimb for each mouse. The 18FDG activities in each ROI were summed across all coronal planes, and expressed as a proportion of 18FDG in the whole mouse (total 18FDG activity was also taken as the sum of activity across coronal planes).
###end p 20
###begin p 21
###xml 0 23 0 23 <bold xmlns:xlink="http://www.w3.org/1999/xlink">Primary myocyte culture</bold>
###xml 99 103 99 103 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Pten</italic>
###xml 103 106 103 106 <sup xmlns:xlink="http://www.w3.org/1999/xlink">+/&#8722;</sup>
###xml 166 168 166 168 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="CR17">17</xref>
###xml 565 566 558 559 <italic xmlns:xlink="http://www.w3.org/1999/xlink">g</italic>
###xml 1360 1362 1353 1355 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="CR18">18</xref>
###xml 107 111 <span type="species:ncbi:10090">mice</span>
###xml 401 407 <span type="species:ncbi:9913">bovine</span>
Primary myocyte culture Primary myocytes were cultured from fore- and hindlimbs from wild-type and Pten+/- mice according to a protocol adapted from Springer et al. [17]. Skeletal muscle was excised and minced and then incubated at 37degreesC for 2 h with 2.4 units/ml dispase II. Dispase digestion was halted by addition of 10 ml F-10-based myocyte medium (400 ml F-10 nutrient mixture, 100 ml fetal bovine serum, 25 mug basic fibroblast growth factor, penicillin/streptomycin). The tissue slurry was then strained through a fine metal mesh and centrifuged at 500 g for 5 min. The supernatant fraction was removed to a fresh centrifuge tube and the pellet was resuspended and plated to a 5-cm collagen-coated culture dish in a total of 4 ml F-10-based medium. The supernatant fraction was re-centrifuged and the pellet was pooled with the first. The cells were passaged when they reached 70-80% confluence. To enrich for myocytes, the old medium was removed by aspiration, the cells washed with PBS, then incubated in a film of this buffer for 15 min. Myocytes were loosened from the dish by striking the dish several times sharply on the bench top. Cells were washed from the dish with PBS. The PBS incubation was repeated and the cells were pooled. Cells kept in culture for more than 5-6 days began to exhibit the elongated morphology typical of myotubes [18]. Cells in these older cultures also exhibited spontaneous twitching. All experiments were performed with cells on days 2-3 of culture.
###end p 21
###begin p 22
###xml 8 9 8 9 <sup xmlns:xlink="http://www.w3.org/1999/xlink">3</sup>
###xml 0 25 0 25 <bold xmlns:xlink="http://www.w3.org/1999/xlink">2-Deoxy[<sup>3</sup>H]glucose uptake</bold>
###xml 69 73 69 73 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Pten</italic>
###xml 73 76 73 76 <sup xmlns:xlink="http://www.w3.org/1999/xlink">+/&#8722;</sup>
###xml 338 339 338 339 <sub xmlns:xlink="http://www.w3.org/1999/xlink">4</sub>
###xml 354 355 354 355 <sub xmlns:xlink="http://www.w3.org/1999/xlink">2</sub>
###xml 419 420 418 419 <sup xmlns:xlink="http://www.w3.org/1999/xlink">3</sup>
###xml 793 794 791 792 <sup xmlns:xlink="http://www.w3.org/1999/xlink">3</sup>
###xml 866 867 864 865 <sup xmlns:xlink="http://www.w3.org/1999/xlink">3</sup>
###xml 948 950 945 947 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="CR19">19</xref>
2-Deoxy[3H]glucose uptake Experiments were performed on wild-type or Pten+/- cells from passage two to eight, grown on 24-well (1-cm diameter wells) plates. Cells were preincubated in serum-free medium for 12 h prior to experiments. The cells were washed twice with HEPES-buffered saline (140 mmol/l NaCl, 20 mmol/l HEPES, 2.5 mmol/l MgSO4, 1 mmol/l CaCl2, 5 mmol/l KCl, pH 7.4), then incubated with 10 mumol/l 2-deoxy[3H]glucose (0.037 MBq/ml) for 5, 10, 20 or 30 min, in the absence or presence of 0.1 mumol/l insulin. At the end of the incubation period, the radioactive substrate was removed, and the cells were washed three times with ice-cold 20 mmol/l glucose. Cells were lysed with 0.2 ml 2% SDS, and the lysates were used for scintillation counting. Non-specific diffusion of 2-deoxy[3H]glucose was determined by incubating cells in the presence of 2-deoxy[3H]glucose and 10 mumol/l cytochalasin B, a specific inhibitor of glucose uptake [19].
###end p 22
###begin p 23
###xml 0 52 0 52 <bold xmlns:xlink="http://www.w3.org/1999/xlink">Determination of cell-surface GLUT1 and GLUT4 levels</bold>
Determination of cell-surface GLUT1 and GLUT4 levels Primary myocytes were grown in 10-cm culture dishes. The cells were rinsed with PBS, and incubated with 0.5 mg/ml sulpho-NHS-LC-biotin (Pierce Biotechnology, Rockford, IL, USA) in PBS for 20 min. Cells are impermeable to this reagent and it labels the amine groups of cell-surface proteins. Following the incubation, the cells were washed three times with PBS, then lysed with 0.5 ml lysis buffer (1% NP-40, 150 mmol/l NaCl, 50 mmol/l Tris pH 7.5, including protease and phosphatase inhibitors). Protein was quantified with a BCA protein assay kit (Pierce). Streptavidin-agarose beads (Pierce) were pre-blocked by incubation with 2% BSA in lysis buffer. Each sample (1.2 mg protein) was incubated with the streptavidin beads (100 mul, 50% bead slurry) for 1 h at room temperature. The beads were washed five times, for 30-60 min each wash, using lysis buffer containing 0.1% SDS. After the final wash, 50 mul SDS sample-loading buffer were added, and heated at 95degreesC for 10 min, then vortexed to elute the biotinylated proteins. The proteins in the supernatant fractions were analysed by SDS-PAGE, then transferred to nitrocellulose. Proteins were probed using polyclonal antibodies against GLUT1 and GLUT4 (also known as SCLA2A1 and SCLA2A4, respectively).
###end p 23
###begin p 24
###xml 0 100 0 93 <bold xmlns:xlink="http://www.w3.org/1999/xlink">Western immunoblotting for PKB, phospho-PKB and phospho-glycogen synthase kinase 3 (GSK3)-&#945;/&#946;</bold>
###xml 315 321 <span type="species:ncbi:9986">Rabbit</span>
###xml 488 493 <span type="species:ncbi:10090">Mouse</span>
###xml 573 584 <span type="species:ncbi:3704">Horseradish</span>
Western immunoblotting for PKB, phospho-PKB and phospho-glycogen synthase kinase 3 (GSK3)-alpha/beta Total protein extracts of primary myocytes were prepared by lysing cells in NP-40-based lysis buffer. Thirty to fifty micrograms of protein per sample were analysed by SDS-PAGE, then transferred to nitrocellulose. Rabbit polyclonal anti-PKB, anti-phospho-PKB (Ser473) and anti-phospho-GSK3-alpha/beta (Ser21/9) antibodies were obtained from Cell Signaling Technology (Beverly, MA, USA). Mouse monoclonal anti-vinculin antibody was obtained from Sigma (St Louis, MO, USA). Horseradish peroxidase-conjugated secondary antibodies were obtained from Dako. Protein bands were visualised using an enhanced chemiluminescence system and autoradiography by exposure to X-ray film.
###end p 24
###begin p 25
###xml 0 20 0 20 <bold xmlns:xlink="http://www.w3.org/1999/xlink">Statistical analysis</bold>
###xml 72 73 72 73 <italic xmlns:xlink="http://www.w3.org/1999/xlink">t</italic>
Statistical analysis Statistical analysis was performed using Student's t test. Significance was assessed at the 95% confidence level.
###end p 25
###begin title 26
Results
###end title 26
###begin p 27
###xml 79 83 79 83 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Pten</italic>
###xml 83 86 83 86 <sup xmlns:xlink="http://www.w3.org/1999/xlink">+/&#8722;</sup>
###xml 131 135 131 135 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Pten</italic>
###xml 135 138 135 138 <sup xmlns:xlink="http://www.w3.org/1999/xlink">+/&#8722;</sup>
###xml 228 232 228 232 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Pten</italic>
###xml 232 235 232 235 <sup xmlns:xlink="http://www.w3.org/1999/xlink">+/&#8722;</sup>
###xml 297 301 297 301 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Pten</italic>
###xml 301 304 301 304 <sup xmlns:xlink="http://www.w3.org/1999/xlink">+/&#8722;</sup>
###xml 318 319 318 319 <xref xmlns:xlink="http://www.w3.org/1999/xlink" rid="Tab1" ref-type="table">1</xref>
###xml 427 431 427 431 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Pten</italic>
###xml 431 434 431 434 <sup xmlns:xlink="http://www.w3.org/1999/xlink">+/&#8722;</sup>
###xml 563 567 563 567 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Pten</italic>
###xml 567 570 567 570 <sup xmlns:xlink="http://www.w3.org/1999/xlink">+/&#8722;</sup>
###xml 582 583 582 583 <xref xmlns:xlink="http://www.w3.org/1999/xlink" rid="Fig1" ref-type="fig">1</xref>
###xml 668 672 668 672 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Pten</italic>
###xml 672 675 672 675 <sup xmlns:xlink="http://www.w3.org/1999/xlink">+/&#8722;</sup>
###xml 914 918 914 918 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Pten</italic>
###xml 918 921 918 921 <sup xmlns:xlink="http://www.w3.org/1999/xlink">+/&#8722;</sup>
###xml 983 984 983 984 <xref xmlns:xlink="http://www.w3.org/1999/xlink" rid="Fig1" ref-type="fig">1</xref>
###xml 1042 1046 1042 1046 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Pten</italic>
###xml 1046 1049 1046 1049 <sup xmlns:xlink="http://www.w3.org/1999/xlink">+/&#8722;</sup>
###xml 1156 1163 1156 1163 <label xmlns:xlink="http://www.w3.org/1999/xlink">Table&#160;1</label>
###xml 1201 1205 1201 1205 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Pten</italic>
###xml 1205 1208 1205 1208 <sup xmlns:xlink="http://www.w3.org/1999/xlink">+/&#8722;</sup>
###xml 1163 1261 1163 1261 <p xmlns:xlink="http://www.w3.org/1999/xlink" textid="28">Blood glucose levels in wild-type and <italic>Pten</italic><sup>+/&#8722;</sup> mice during ad libitum feeding and after a 15-h fast</p>
###xml 1163 1261 1163 1261 <caption xmlns:xlink="http://www.w3.org/1999/xlink"><p textid="28">Blood glucose levels in wild-type and <italic>Pten</italic><sup>+/&#8722;</sup> mice during ad libitum feeding and after a 15-h fast</p></caption>
###xml 1261 1262 1261 1262 <th xmlns:xlink="http://www.w3.org/1999/xlink" rowspan="2">&#160;</th>
###xml 1262 1294 1262 1292 <th xmlns:xlink="http://www.w3.org/1999/xlink" colspan="2">Mean blood glucose&#177;SD (mmol/l)</th>
###xml 1294 1295 1292 1293 <italic xmlns:xlink="http://www.w3.org/1999/xlink">p</italic>
###xml 1325 1326 1323 1324 <italic xmlns:xlink="http://www.w3.org/1999/xlink">t</italic>
###xml 1294 1332 1292 1330 <th xmlns:xlink="http://www.w3.org/1999/xlink" rowspan="2"><italic>p</italic> value (independent Student&#8217;s <italic>t</italic> test)</th>
###xml 1261 1332 1261 1330 <tr xmlns:xlink="http://www.w3.org/1999/xlink"><th rowspan="2">&#160;</th><th colspan="2">Mean blood glucose&#177;SD (mmol/l)</th><th rowspan="2"><italic>p</italic> value (independent Student&#8217;s <italic>t</italic> test)</th></tr>
###xml 1332 1341 1330 1339 <th xmlns:xlink="http://www.w3.org/1999/xlink">Wild-type</th>
###xml 1345 1348 1343 1346 <sup xmlns:xlink="http://www.w3.org/1999/xlink">+/&#8722;</sup>
###xml 1341 1348 1339 1346 <th xmlns:xlink="http://www.w3.org/1999/xlink">Pten<sup>+/&#8722;</sup></th>
###xml 1332 1348 1330 1346 <tr xmlns:xlink="http://www.w3.org/1999/xlink"><th>Wild-type</th><th>Pten<sup>+/&#8722;</sup></th></tr>
###xml 1261 1348 1261 1346 <thead xmlns:xlink="http://www.w3.org/1999/xlink"><tr><th rowspan="2">&#160;</th><th colspan="2">Mean blood glucose&#177;SD (mmol/l)</th><th rowspan="2"><italic>p</italic> value (independent Student&#8217;s <italic>t</italic> test)</th></tr><tr><th>Wild-type</th><th>Pten<sup>+/&#8722;</sup></th></tr></thead>
###xml 1348 1366 1346 1364 <td xmlns:xlink="http://www.w3.org/1999/xlink">Ad libitum feeding</td>
###xml 1379 1380 1375 1376 <italic xmlns:xlink="http://www.w3.org/1999/xlink">n</italic>
###xml 1366 1385 1364 1381 <td xmlns:xlink="http://www.w3.org/1999/xlink">7.1&#8201;&#177;&#8201;0.4 (<italic>n</italic>&#8201;=&#8201;5)</td>
###xml 1398 1399 1392 1393 <italic xmlns:xlink="http://www.w3.org/1999/xlink">n</italic>
###xml 1385 1404 1381 1398 <td xmlns:xlink="http://www.w3.org/1999/xlink">6.3&#8201;&#177;&#8201;0.2 (<italic>n</italic>&#8201;=&#8201;4)</td>
###xml 1404 1409 1398 1403 <td xmlns:xlink="http://www.w3.org/1999/xlink">0.006</td>
###xml 1348 1409 1346 1403 <tr xmlns:xlink="http://www.w3.org/1999/xlink"><td>Ad libitum feeding</td><td>7.1&#8201;&#177;&#8201;0.4 (<italic>n</italic>&#8201;=&#8201;5)</td><td>6.3&#8201;&#177;&#8201;0.2 (<italic>n</italic>&#8201;=&#8201;4)</td><td>0.006</td></tr>
###xml 1409 1416 1403 1410 <td xmlns:xlink="http://www.w3.org/1999/xlink">Fasting</td>
###xml 1429 1430 1421 1422 <italic xmlns:xlink="http://www.w3.org/1999/xlink">n</italic>
###xml 1416 1435 1410 1427 <td xmlns:xlink="http://www.w3.org/1999/xlink">6.5&#8201;&#177;&#8201;0.3 (<italic>n</italic>&#8201;=&#8201;5)</td>
###xml 1448 1449 1438 1439 <italic xmlns:xlink="http://www.w3.org/1999/xlink">n</italic>
###xml 1435 1454 1427 1444 <td xmlns:xlink="http://www.w3.org/1999/xlink">5.8&#8201;&#177;&#8201;0.3 (<italic>n</italic>&#8201;=&#8201;5)</td>
###xml 1454 1459 1444 1449 <td xmlns:xlink="http://www.w3.org/1999/xlink">0.008</td>
###xml 1409 1459 1403 1449 <tr xmlns:xlink="http://www.w3.org/1999/xlink"><td>Fasting</td><td>6.5&#8201;&#177;&#8201;0.3 (<italic>n</italic>&#8201;=&#8201;5)</td><td>5.8&#8201;&#177;&#8201;0.3 (<italic>n</italic>&#8201;=&#8201;5)</td><td>0.008</td></tr>
###xml 1348 1459 1346 1449 <tbody xmlns:xlink="http://www.w3.org/1999/xlink"><tr><td>Ad libitum feeding</td><td>7.1&#8201;&#177;&#8201;0.4 (<italic>n</italic>&#8201;=&#8201;5)</td><td>6.3&#8201;&#177;&#8201;0.2 (<italic>n</italic>&#8201;=&#8201;4)</td><td>0.006</td></tr><tr><td>Fasting</td><td>6.5&#8201;&#177;&#8201;0.3 (<italic>n</italic>&#8201;=&#8201;5)</td><td>5.8&#8201;&#177;&#8201;0.3 (<italic>n</italic>&#8201;=&#8201;5)</td><td>0.008</td></tr></tbody>
###xml 1261 1459 1261 1449 <table xmlns:xlink="http://www.w3.org/1999/xlink" frame="hsides" rules="groups"><thead><tr><th rowspan="2">&#160;</th><th colspan="2">Mean blood glucose&#177;SD (mmol/l)</th><th rowspan="2"><italic>p</italic> value (independent Student&#8217;s <italic>t</italic> test)</th></tr><tr><th>Wild-type</th><th>Pten<sup>+/&#8722;</sup></th></tr></thead><tbody><tr><td>Ad libitum feeding</td><td>7.1&#8201;&#177;&#8201;0.4 (<italic>n</italic>&#8201;=&#8201;5)</td><td>6.3&#8201;&#177;&#8201;0.2 (<italic>n</italic>&#8201;=&#8201;4)</td><td>0.006</td></tr><tr><td>Fasting</td><td>6.5&#8201;&#177;&#8201;0.3 (<italic>n</italic>&#8201;=&#8201;5)</td><td>5.8&#8201;&#177;&#8201;0.3 (<italic>n</italic>&#8201;=&#8201;5)</td><td>0.008</td></tr></tbody></table>
###xml 1156 1459 1156 1449 <table-wrap xmlns:xlink="http://www.w3.org/1999/xlink" id="Tab1"><label>Table&#160;1</label><caption><p textid="28">Blood glucose levels in wild-type and <italic>Pten</italic><sup>+/&#8722;</sup> mice during ad libitum feeding and after a 15-h fast</p></caption><table frame="hsides" rules="groups"><thead><tr><th rowspan="2">&#160;</th><th colspan="2">Mean blood glucose&#177;SD (mmol/l)</th><th rowspan="2"><italic>p</italic> value (independent Student&#8217;s <italic>t</italic> test)</th></tr><tr><th>Wild-type</th><th>Pten<sup>+/&#8722;</sup></th></tr></thead><tbody><tr><td>Ad libitum feeding</td><td>7.1&#8201;&#177;&#8201;0.4 (<italic>n</italic>&#8201;=&#8201;5)</td><td>6.3&#8201;&#177;&#8201;0.2 (<italic>n</italic>&#8201;=&#8201;4)</td><td>0.006</td></tr><tr><td>Fasting</td><td>6.5&#8201;&#177;&#8201;0.3 (<italic>n</italic>&#8201;=&#8201;5)</td><td>5.8&#8201;&#177;&#8201;0.3 (<italic>n</italic>&#8201;=&#8201;5)</td><td>0.008</td></tr></tbody></table></table-wrap>
###xml 1459 1465 1449 1455 <label xmlns:xlink="http://www.w3.org/1999/xlink">Fig.&#160;1</label>
###xml 1493 1497 1483 1487 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Pten</italic>
###xml 1497 1500 1487 1490 <sup xmlns:xlink="http://www.w3.org/1999/xlink">+/&#8722;</sup>
###xml 1506 1507 1496 1497 <bold xmlns:xlink="http://www.w3.org/1999/xlink">a</bold>
###xml 1714 1727 1702 1715 <italic xmlns:xlink="http://www.w3.org/1999/xlink">white circles</italic>
###xml 1737 1741 1725 1729 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Pten</italic>
###xml 1741 1744 1729 1732 <sup xmlns:xlink="http://www.w3.org/1999/xlink">+/&#8722;</sup>
###xml 1751 1764 1739 1752 <italic xmlns:xlink="http://www.w3.org/1999/xlink">black circles</italic>
###xml 1767 1768 1755 1756 <bold xmlns:xlink="http://www.w3.org/1999/xlink">b</bold>
###xml 1913 1926 1899 1912 <italic xmlns:xlink="http://www.w3.org/1999/xlink">white circles</italic>
###xml 1938 1942 1924 1928 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Pten</italic>
###xml 1942 1945 1928 1931 <sup xmlns:xlink="http://www.w3.org/1999/xlink">+/&#8722;</sup>
###xml 1952 1965 1938 1951 <italic xmlns:xlink="http://www.w3.org/1999/xlink">black circles</italic>
###xml 1465 1966 1455 1952 <p xmlns:xlink="http://www.w3.org/1999/xlink" textid="29">Insulin hypersensitivity in <italic>Pten</italic><sup>+/&#8722;</sup>mice. <bold>a</bold> Insulin challenge test. Mice were fasted for 15&#160;h prior to i.p. injection of insulin (0.6&#160;mU/g body weight). Blood glucose levels were determined at the indicated times. Means&#177;SEM for six wild-type mice (<italic>white circles</italic>) and six <italic>Pten</italic><sup>+/&#8722;</sup> mice (<italic>black circles</italic>). <bold>b</bold> Glucose tolerance test. Mice were fasted for 15&#160;h prior to i.p. injection of glucose at 2&#160;mg/g body weight. Means&#177;SEM for six wild-type mice (<italic>white circles</italic>) and seven <italic>Pten</italic><sup>+/&#8722;</sup> mice (<italic>black circles</italic>)</p>
###xml 1465 1966 1455 1952 <caption xmlns:xlink="http://www.w3.org/1999/xlink"><p textid="29">Insulin hypersensitivity in <italic>Pten</italic><sup>+/&#8722;</sup>mice. <bold>a</bold> Insulin challenge test. Mice were fasted for 15&#160;h prior to i.p. injection of insulin (0.6&#160;mU/g body weight). Blood glucose levels were determined at the indicated times. Means&#177;SEM for six wild-type mice (<italic>white circles</italic>) and six <italic>Pten</italic><sup>+/&#8722;</sup> mice (<italic>black circles</italic>). <bold>b</bold> Glucose tolerance test. Mice were fasted for 15&#160;h prior to i.p. injection of glucose at 2&#160;mg/g body weight. Means&#177;SEM for six wild-type mice (<italic>white circles</italic>) and seven <italic>Pten</italic><sup>+/&#8722;</sup> mice (<italic>black circles</italic>)</p></caption>
###xml 1966 1966 1952 1952 <graphic xmlns:xlink="http://www.w3.org/1999/xlink" position="anchor" xlink:href="125_2006_531_Fig1_HTML" id="MO1"/>
###xml 1459 1966 1449 1952 <fig xmlns:xlink="http://www.w3.org/1999/xlink" id="Fig1"><label>Fig.&#160;1</label><caption><p textid="29">Insulin hypersensitivity in <italic>Pten</italic><sup>+/&#8722;</sup>mice. <bold>a</bold> Insulin challenge test. Mice were fasted for 15&#160;h prior to i.p. injection of insulin (0.6&#160;mU/g body weight). Blood glucose levels were determined at the indicated times. Means&#177;SEM for six wild-type mice (<italic>white circles</italic>) and six <italic>Pten</italic><sup>+/&#8722;</sup> mice (<italic>black circles</italic>). <bold>b</bold> Glucose tolerance test. Mice were fasted for 15&#160;h prior to i.p. injection of glucose at 2&#160;mg/g body weight. Means&#177;SEM for six wild-type mice (<italic>white circles</italic>) and seven <italic>Pten</italic><sup>+/&#8722;</sup> mice (<italic>black circles</italic>)</p></caption><graphic position="anchor" xlink:href="125_2006_531_Fig1_HTML" id="MO1"/></fig>
###xml 87 91 <span type="species:ncbi:10090">mice</span>
###xml 139 143 <span type="species:ncbi:10090">mice</span>
###xml 236 240 <span type="species:ncbi:10090">mice</span>
###xml 305 309 <span type="species:ncbi:10090">mice</span>
###xml 491 495 <span type="species:ncbi:10090">mice</span>
###xml 571 575 <span type="species:ncbi:10090">mice</span>
###xml 676 680 <span type="species:ncbi:10090">mice</span>
###xml 768 772 <span type="species:ncbi:10090">mice</span>
###xml 922 926 <span type="species:ncbi:10090">mice</span>
###xml 972 976 <span type="species:ncbi:10090">mice</span>
###xml 1050 1054 <span type="species:ncbi:10090">mice</span>
###xml 1150 1154 <span type="species:ncbi:10090">mice</span>
###xml 1209 1213 <span type="species:ncbi:10090">mice</span>
###xml 1500 1504 <span type="species:ncbi:10090">mice</span>
###xml 1532 1536 <span type="species:ncbi:10090">Mice</span>
###xml 1708 1712 <span type="species:ncbi:10090">mice</span>
###xml 1745 1749 <span type="species:ncbi:10090">mice</span>
###xml 1793 1797 <span type="species:ncbi:10090">Mice</span>
###xml 1907 1911 <span type="species:ncbi:10090">mice</span>
###xml 1946 1950 <span type="species:ncbi:10090">mice</span>
As glucose metabolism may be altered due to a change in insulin sensitivity in Pten+/- mice, blood glucose levels in wild-type and Pten+/- mice were determined. Slight but statistically significant hypoglycaemia was observed in Pten+/- mice during ad libitum feeding (11.3% lower blood glucose in Pten+/- mice) (Table 1). Fasting caused a drop in glucose levels in both groups, with slight but significant hypoglycaemia in the Pten+/- group (10.8% lower blood glucose) relative to wild-type mice. An insulin challenge test revealed hypersensitivity to insulin in Pten+/- mice (Fig. 1a). Following i.p. insulin injection (0.6 mU/g body weight), blood glucose levels in Pten+/- mice remained depressed at all time-points measured (up to 120 min). In contrast, wild-type mice started to recover after 30 min, and glucose levels returned to fasting levels 120 min after injection. A glucose tolerance test showed that Pten+/- mice had greater glucose tolerance than wild-type mice (Fig. 1b). After i.p. glucose injection, blood glucose levels in Pten+/- mice returned to fasting levels in less than 60 min, approximately twice as rapidly as in wild-type mice. Table 1Blood glucose levels in wild-type and Pten+/- mice during ad libitum feeding and after a 15-h fast Mean blood glucose+/-SD (mmol/l)p value (independent Student's t test)Wild-typePten+/-Ad libitum feeding7.1 +/- 0.4 (n = 5)6.3 +/- 0.2 (n = 4)0.006Fasting6.5 +/- 0.3 (n = 5)5.8 +/- 0.3 (n = 5)0.008Fig. 1Insulin hypersensitivity in Pten+/-mice. a Insulin challenge test. Mice were fasted for 15 h prior to i.p. injection of insulin (0.6 mU/g body weight). Blood glucose levels were determined at the indicated times. Means+/-SEM for six wild-type mice (white circles) and six Pten+/- mice (black circles). b Glucose tolerance test. Mice were fasted for 15 h prior to i.p. injection of glucose at 2 mg/g body weight. Means+/-SEM for six wild-type mice (white circles) and seven Pten+/- mice (black circles)
###end p 27
###begin p 28
###xml 38 42 38 42 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Pten</italic>
###xml 42 45 42 45 <sup xmlns:xlink="http://www.w3.org/1999/xlink">+/&#8722;</sup>
###xml 46 50 <span type="species:ncbi:10090">mice</span>
Blood glucose levels in wild-type and Pten+/- mice during ad libitum feeding and after a 15-h fast
###end p 28
###begin p 29
###xml 28 32 28 32 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Pten</italic>
###xml 32 35 32 35 <sup xmlns:xlink="http://www.w3.org/1999/xlink">+/&#8722;</sup>
###xml 41 42 41 42 <bold xmlns:xlink="http://www.w3.org/1999/xlink">a</bold>
###xml 249 262 247 260 <italic xmlns:xlink="http://www.w3.org/1999/xlink">white circles</italic>
###xml 272 276 270 274 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Pten</italic>
###xml 276 279 274 277 <sup xmlns:xlink="http://www.w3.org/1999/xlink">+/&#8722;</sup>
###xml 286 299 284 297 <italic xmlns:xlink="http://www.w3.org/1999/xlink">black circles</italic>
###xml 302 303 300 301 <bold xmlns:xlink="http://www.w3.org/1999/xlink">b</bold>
###xml 448 461 444 457 <italic xmlns:xlink="http://www.w3.org/1999/xlink">white circles</italic>
###xml 473 477 469 473 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Pten</italic>
###xml 477 480 473 476 <sup xmlns:xlink="http://www.w3.org/1999/xlink">+/&#8722;</sup>
###xml 487 500 483 496 <italic xmlns:xlink="http://www.w3.org/1999/xlink">black circles</italic>
###xml 35 39 <span type="species:ncbi:10090">mice</span>
###xml 67 71 <span type="species:ncbi:10090">Mice</span>
###xml 243 247 <span type="species:ncbi:10090">mice</span>
###xml 280 284 <span type="species:ncbi:10090">mice</span>
###xml 328 332 <span type="species:ncbi:10090">Mice</span>
###xml 442 446 <span type="species:ncbi:10090">mice</span>
###xml 481 485 <span type="species:ncbi:10090">mice</span>
Insulin hypersensitivity in Pten+/-mice. a Insulin challenge test. Mice were fasted for 15 h prior to i.p. injection of insulin (0.6 mU/g body weight). Blood glucose levels were determined at the indicated times. Means+/-SEM for six wild-type mice (white circles) and six Pten+/- mice (black circles). b Glucose tolerance test. Mice were fasted for 15 h prior to i.p. injection of glucose at 2 mg/g body weight. Means+/-SEM for six wild-type mice (white circles) and seven Pten+/- mice (black circles)
###end p 29
###begin p 30
###xml 353 357 353 357 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Pten</italic>
###xml 357 360 357 360 <sup xmlns:xlink="http://www.w3.org/1999/xlink">+/&#8722;</sup>
###xml 373 374 373 374 <xref xmlns:xlink="http://www.w3.org/1999/xlink" rid="Tab2" ref-type="table">2</xref>
###xml 599 600 599 600 <xref xmlns:xlink="http://www.w3.org/1999/xlink" rid="Tab2" ref-type="table">2</xref>
###xml 678 682 678 682 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Pten</italic>
###xml 682 685 682 685 <sup xmlns:xlink="http://www.w3.org/1999/xlink">+/&#8722;</sup>
###xml 735 739 735 739 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Pten</italic>
###xml 739 742 739 742 <sup xmlns:xlink="http://www.w3.org/1999/xlink">+/+</sup>
###xml 747 751 747 751 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Pten</italic>
###xml 751 754 751 754 <sup xmlns:xlink="http://www.w3.org/1999/xlink">+/&#8722;</sup>
###xml 816 837 816 837 <xref xmlns:xlink="http://www.w3.org/1999/xlink" rid="Sec2" ref-type="sec">Materials and methods</xref>
###xml 1157 1161 1155 1159 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Pten</italic>
###xml 1161 1164 1159 1162 <sup xmlns:xlink="http://www.w3.org/1999/xlink">+/+</sup>
###xml 1182 1186 1178 1182 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Pten</italic>
###xml 1186 1189 1182 1185 <sup xmlns:xlink="http://www.w3.org/1999/xlink">+/&#8722;</sup>
###xml 1205 1206 1199 1200 <italic xmlns:xlink="http://www.w3.org/1999/xlink">p</italic>
###xml 1241 1242 1235 1236 <italic xmlns:xlink="http://www.w3.org/1999/xlink">n</italic>
###xml 1276 1280 1270 1274 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Pten</italic>
###xml 1280 1283 1274 1277 <sup xmlns:xlink="http://www.w3.org/1999/xlink">+/+</sup>
###xml 1301 1305 1293 1297 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Pten</italic>
###xml 1305 1308 1297 1300 <sup xmlns:xlink="http://www.w3.org/1999/xlink">+/&#8722;</sup>
###xml 1324 1325 1314 1315 <italic xmlns:xlink="http://www.w3.org/1999/xlink">p</italic>
###xml 1360 1361 1350 1351 <italic xmlns:xlink="http://www.w3.org/1999/xlink">n</italic>
###xml 1378 1385 1368 1375 <label xmlns:xlink="http://www.w3.org/1999/xlink">Table&#160;2</label>
###xml 1424 1428 1414 1418 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Pten</italic>
###xml 1428 1431 1418 1421 <sup xmlns:xlink="http://www.w3.org/1999/xlink">+/&#8722;</sup>
###xml 1385 1525 1375 1515 <p xmlns:xlink="http://www.w3.org/1999/xlink" textid="31">Plasma insulin levels in wild-type and <italic>Pten</italic><sup>+/&#8722;</sup> mice after fasting, and 15&#160;min after i.p. glucose administration (2&#160;mg glucose/g body weight)</p>
###xml 1385 1525 1375 1515 <caption xmlns:xlink="http://www.w3.org/1999/xlink"><p textid="31">Plasma insulin levels in wild-type and <italic>Pten</italic><sup>+/&#8722;</sup> mice after fasting, and 15&#160;min after i.p. glucose administration (2&#160;mg glucose/g body weight)</p></caption>
###xml 1525 1526 1515 1516 <th xmlns:xlink="http://www.w3.org/1999/xlink" rowspan="2">&#160;</th>
###xml 1526 1558 1516 1546 <th xmlns:xlink="http://www.w3.org/1999/xlink" colspan="2">Mean plasma insulin&#177;SD (ng/ml)</th>
###xml 1558 1559 1546 1547 <italic xmlns:xlink="http://www.w3.org/1999/xlink">p</italic>
###xml 1589 1590 1577 1578 <italic xmlns:xlink="http://www.w3.org/1999/xlink">t</italic>
###xml 1558 1596 1546 1584 <th xmlns:xlink="http://www.w3.org/1999/xlink" rowspan="2"><italic>p</italic> value (independent Student&#8217;s <italic>t</italic> test)</th>
###xml 1525 1596 1515 1584 <tr xmlns:xlink="http://www.w3.org/1999/xlink"><th rowspan="2">&#160;</th><th colspan="2">Mean plasma insulin&#177;SD (ng/ml)</th><th rowspan="2"><italic>p</italic> value (independent Student&#8217;s <italic>t</italic> test)</th></tr>
###xml 1607 1608 1595 1596 <italic xmlns:xlink="http://www.w3.org/1999/xlink">n</italic>
###xml 1596 1613 1584 1601 <th xmlns:xlink="http://www.w3.org/1999/xlink">Wild-type (<italic>n</italic>&#8201;=&#8201;7)</th>
###xml 1617 1620 1605 1608 <sup xmlns:xlink="http://www.w3.org/1999/xlink">+/&#8722;</sup>
###xml 1622 1623 1610 1611 <italic xmlns:xlink="http://www.w3.org/1999/xlink">n</italic>
###xml 1613 1628 1601 1616 <th xmlns:xlink="http://www.w3.org/1999/xlink">Pten<sup>+/&#8722;</sup> (<italic>n</italic>&#8201;=&#8201;6)</th>
###xml 1596 1628 1584 1616 <tr xmlns:xlink="http://www.w3.org/1999/xlink"><th>Wild-type (<italic>n</italic>&#8201;=&#8201;7)</th><th>Pten<sup>+/&#8722;</sup> (<italic>n</italic>&#8201;=&#8201;6)</th></tr>
###xml 1525 1628 1515 1616 <thead xmlns:xlink="http://www.w3.org/1999/xlink"><tr><th rowspan="2">&#160;</th><th colspan="2">Mean plasma insulin&#177;SD (ng/ml)</th><th rowspan="2"><italic>p</italic> value (independent Student&#8217;s <italic>t</italic> test)</th></tr><tr><th>Wild-type (<italic>n</italic>&#8201;=&#8201;7)</th><th>Pten<sup>+/&#8722;</sup> (<italic>n</italic>&#8201;=&#8201;6)</th></tr></thead>
###xml 1628 1635 1616 1623 <td xmlns:xlink="http://www.w3.org/1999/xlink">Fasting</td>
###xml 1635 1648 1623 1634 <td xmlns:xlink="http://www.w3.org/1999/xlink">0.50&#8201;&#177;&#8201;0.04</td>
###xml 1648 1661 1634 1645 <td xmlns:xlink="http://www.w3.org/1999/xlink">0.36&#8201;&#177;&#8201;0.10</td>
###xml 1661 1665 1645 1649 <td xmlns:xlink="http://www.w3.org/1999/xlink">0.05</td>
###xml 1628 1665 1616 1649 <tr xmlns:xlink="http://www.w3.org/1999/xlink"><td>Fasting</td><td>0.50&#8201;&#177;&#8201;0.04</td><td>0.36&#8201;&#177;&#8201;0.10</td><td>0.05</td></tr>
###xml 1665 1687 1649 1671 <td xmlns:xlink="http://www.w3.org/1999/xlink">Post-glucose challenge</td>
###xml 1687 1698 1671 1680 <td xmlns:xlink="http://www.w3.org/1999/xlink">1.8&#8201;&#177;&#8201;0.5</td>
###xml 1698 1709 1680 1689 <td xmlns:xlink="http://www.w3.org/1999/xlink">2.4&#8201;&#177;&#8201;0.4</td>
###xml 1709 1732 1689 1712 <td xmlns:xlink="http://www.w3.org/1999/xlink">&gt;0.05 (not significant)</td>
###xml 1665 1732 1649 1712 <tr xmlns:xlink="http://www.w3.org/1999/xlink"><td>Post-glucose challenge</td><td>1.8&#8201;&#177;&#8201;0.5</td><td>2.4&#8201;&#177;&#8201;0.4</td><td>&gt;0.05 (not significant)</td></tr>
###xml 1628 1732 1616 1712 <tbody xmlns:xlink="http://www.w3.org/1999/xlink"><tr><td>Fasting</td><td>0.50&#8201;&#177;&#8201;0.04</td><td>0.36&#8201;&#177;&#8201;0.10</td><td>0.05</td></tr><tr><td>Post-glucose challenge</td><td>1.8&#8201;&#177;&#8201;0.5</td><td>2.4&#8201;&#177;&#8201;0.4</td><td>&gt;0.05 (not significant)</td></tr></tbody>
###xml 1525 1732 1515 1712 <table xmlns:xlink="http://www.w3.org/1999/xlink" frame="hsides" rules="groups"><thead><tr><th rowspan="2">&#160;</th><th colspan="2">Mean plasma insulin&#177;SD (ng/ml)</th><th rowspan="2"><italic>p</italic> value (independent Student&#8217;s <italic>t</italic> test)</th></tr><tr><th>Wild-type (<italic>n</italic>&#8201;=&#8201;7)</th><th>Pten<sup>+/&#8722;</sup> (<italic>n</italic>&#8201;=&#8201;6)</th></tr></thead><tbody><tr><td>Fasting</td><td>0.50&#8201;&#177;&#8201;0.04</td><td>0.36&#8201;&#177;&#8201;0.10</td><td>0.05</td></tr><tr><td>Post-glucose challenge</td><td>1.8&#8201;&#177;&#8201;0.5</td><td>2.4&#8201;&#177;&#8201;0.4</td><td>&gt;0.05 (not significant)</td></tr></tbody></table>
###xml 1378 1732 1368 1712 <table-wrap xmlns:xlink="http://www.w3.org/1999/xlink" id="Tab2"><label>Table&#160;2</label><caption><p textid="31">Plasma insulin levels in wild-type and <italic>Pten</italic><sup>+/&#8722;</sup> mice after fasting, and 15&#160;min after i.p. glucose administration (2&#160;mg glucose/g body weight)</p></caption><table frame="hsides" rules="groups"><thead><tr><th rowspan="2">&#160;</th><th colspan="2">Mean plasma insulin&#177;SD (ng/ml)</th><th rowspan="2"><italic>p</italic> value (independent Student&#8217;s <italic>t</italic> test)</th></tr><tr><th>Wild-type (<italic>n</italic>&#8201;=&#8201;7)</th><th>Pten<sup>+/&#8722;</sup> (<italic>n</italic>&#8201;=&#8201;6)</th></tr></thead><tbody><tr><td>Fasting</td><td>0.50&#8201;&#177;&#8201;0.04</td><td>0.36&#8201;&#177;&#8201;0.10</td><td>0.05</td></tr><tr><td>Post-glucose challenge</td><td>1.8&#8201;&#177;&#8201;0.5</td><td>2.4&#8201;&#177;&#8201;0.4</td><td>&gt;0.05 (not significant)</td></tr></tbody></table></table-wrap>
###xml 210 214 <span type="species:ncbi:10090">mice</span>
###xml 361 365 <span type="species:ncbi:10090">mice</span>
###xml 686 690 <span type="species:ncbi:10090">mice</span>
###xml 755 759 <span type="species:ncbi:10090">mice</span>
###xml 1432 1436 <span type="species:ncbi:10090">mice</span>
The observed difference in ability to normalise blood glucose levels could be due to differences in insulin sensitivity or islet function and insulin production. We therefore investigated insulin levels in the mice, as well as properties of pancreatic cell morphology and function. Fasting plasma insulin levels were slightly but significantly lower in Pten+/- mice (Table 2), which is consistent with increased peripheral insulin sensitivity. Fifteen minutes after i.p. glucose administration (2 mg glucose/g body weight), similar increases in plasma insulin were observed in the two groups (Table 2), suggesting that there is no marked difference in insulin production in the Pten+/- mice. Insulin released from islets isolated from Pten+/+ and Pten+/- mice was also examined. Islets were cultured as described in Materials and methods, and incubated in the presence of low (1.67 mmol/l) or high (16.7 mmol/l) glucose. Insulin released into the medium was determined by ELISA and calculated as percentage of total insulin content in the islets. Per cent of total insulin release (presented as mean value+/-SD) was similar under conditions of low glucose (Pten+/+, 3.3 +/- 0.4% vs Pten+/-, 2.8 +/- 0.3%; p > 0.05 no significant difference, n = 3 per group) and high glucose (Pten+/+, 4.2 +/- 0.7% vs Pten+/-, 3.7 +/- 0.2%; p > 0.05 no significant difference, n = 3 per group). Table 2Plasma insulin levels in wild-type and Pten+/- mice after fasting, and 15 min after i.p. glucose administration (2 mg glucose/g body weight) Mean plasma insulin+/-SD (ng/ml)p value (independent Student's t test)Wild-type (n = 7)Pten+/- (n = 6)Fasting0.50 +/- 0.040.36 +/- 0.100.05Post-glucose challenge1.8 +/- 0.52.4 +/- 0.4>0.05 (not significant)
###end p 30
###begin p 31
###xml 39 43 39 43 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Pten</italic>
###xml 43 46 43 46 <sup xmlns:xlink="http://www.w3.org/1999/xlink">+/&#8722;</sup>
###xml 47 51 <span type="species:ncbi:10090">mice</span>
Plasma insulin levels in wild-type and Pten+/- mice after fasting, and 15 min after i.p. glucose administration (2 mg glucose/g body weight)
###end p 31
###begin p 32
###xml 97 101 97 101 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Pten</italic>
###xml 101 104 101 104 <sup xmlns:xlink="http://www.w3.org/1999/xlink">+/&#8722;</sup>
###xml 116 117 116 117 <xref xmlns:xlink="http://www.w3.org/1999/xlink" rid="Fig2" ref-type="fig">2</xref>
###xml 131 135 131 135 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Pten</italic>
###xml 291 295 291 295 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Pten</italic>
###xml 295 298 295 298 <sup xmlns:xlink="http://www.w3.org/1999/xlink">+/&#8722;</sup>
###xml 311 312 311 312 <xref xmlns:xlink="http://www.w3.org/1999/xlink" rid="Tab3" ref-type="table">3</xref>
###xml 315 321 315 321 <label xmlns:xlink="http://www.w3.org/1999/xlink">Fig.&#160;2</label>
###xml 387 392 387 392 <italic xmlns:xlink="http://www.w3.org/1999/xlink">green</italic>
###xml 408 411 408 411 <italic xmlns:xlink="http://www.w3.org/1999/xlink">red</italic>
###xml 427 428 427 428 <bold xmlns:xlink="http://www.w3.org/1999/xlink">a</bold>
###xml 434 438 434 438 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Pten</italic>
###xml 438 441 438 441 <sup xmlns:xlink="http://www.w3.org/1999/xlink">+/&#8722;</sup>
###xml 443 444 443 444 <bold xmlns:xlink="http://www.w3.org/1999/xlink">b</bold>
###xml 507 528 507 528 <xref xmlns:xlink="http://www.w3.org/1999/xlink" rid="Sec2" ref-type="sec">Materials and methods</xref>
###xml 321 598 321 598 <p xmlns:xlink="http://www.w3.org/1999/xlink" textid="33">Pancreatic islet morphology and immunohistochemistry for insulin (<italic>green</italic>) and glucagon (<italic>red</italic>) in wild-type (<bold>a</bold>) and <italic>Pten</italic><sup>+/&#8722;</sup> (<bold>b</bold>) mice. Pancreatic sections were immunostained as described in <xref rid="Sec2" ref-type="sec">Materials and methods</xref> and visualised by fluorescence microscopy. Original magnification &#215;40</p>
###xml 321 598 321 598 <caption xmlns:xlink="http://www.w3.org/1999/xlink"><p textid="33">Pancreatic islet morphology and immunohistochemistry for insulin (<italic>green</italic>) and glucagon (<italic>red</italic>) in wild-type (<bold>a</bold>) and <italic>Pten</italic><sup>+/&#8722;</sup> (<bold>b</bold>) mice. Pancreatic sections were immunostained as described in <xref rid="Sec2" ref-type="sec">Materials and methods</xref> and visualised by fluorescence microscopy. Original magnification &#215;40</p></caption>
###xml 598 598 598 598 <graphic xmlns:xlink="http://www.w3.org/1999/xlink" position="anchor" xlink:href="125_2006_531_Fig2_HTML" id="MO2"/>
###xml 315 598 315 598 <fig xmlns:xlink="http://www.w3.org/1999/xlink" id="Fig2"><label>Fig.&#160;2</label><caption><p textid="33">Pancreatic islet morphology and immunohistochemistry for insulin (<italic>green</italic>) and glucagon (<italic>red</italic>) in wild-type (<bold>a</bold>) and <italic>Pten</italic><sup>+/&#8722;</sup> (<bold>b</bold>) mice. Pancreatic sections were immunostained as described in <xref rid="Sec2" ref-type="sec">Materials and methods</xref> and visualised by fluorescence microscopy. Original magnification &#215;40</p></caption><graphic position="anchor" xlink:href="125_2006_531_Fig2_HTML" id="MO2"/></fig>
###xml 598 605 598 605 <label xmlns:xlink="http://www.w3.org/1999/xlink">Table&#160;3</label>
###xml 634 638 634 638 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Pten</italic>
###xml 638 641 638 641 <sup xmlns:xlink="http://www.w3.org/1999/xlink">+/+</sup>
###xml 646 650 646 650 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Pten</italic>
###xml 650 653 650 653 <sup xmlns:xlink="http://www.w3.org/1999/xlink">+/&#8722;</sup>
###xml 605 665 605 665 <p xmlns:xlink="http://www.w3.org/1999/xlink" textid="34">Pancreatic beta cell mass of <italic>Pten</italic><sup>+/+</sup> and <italic>Pten</italic><sup>+/&#8722;</sup> littermates</p>
###xml 605 665 605 665 <caption xmlns:xlink="http://www.w3.org/1999/xlink"><p textid="34">Pancreatic beta cell mass of <italic>Pten</italic><sup>+/+</sup> and <italic>Pten</italic><sup>+/&#8722;</sup> littermates</p></caption>
###xml 665 666 665 666 <th xmlns:xlink="http://www.w3.org/1999/xlink">&#160;</th>
###xml 666 695 666 693 <th xmlns:xlink="http://www.w3.org/1999/xlink">Mean beta cell mass&#177;SE (mg)</th>
###xml 665 695 665 693 <tr xmlns:xlink="http://www.w3.org/1999/xlink"><th>&#160;</th><th>Mean beta cell mass&#177;SE (mg)</th></tr>
###xml 665 695 665 693 <thead xmlns:xlink="http://www.w3.org/1999/xlink"><tr><th>&#160;</th><th>Mean beta cell mass&#177;SE (mg)</th></tr></thead>
###xml 695 699 693 697 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Pten</italic>
###xml 699 702 697 700 <sup xmlns:xlink="http://www.w3.org/1999/xlink">+/+</sup>
###xml 695 702 693 700 <td xmlns:xlink="http://www.w3.org/1999/xlink"><italic>Pten</italic><sup>+/+</sup></td>
###xml 717 718 713 714 <italic xmlns:xlink="http://www.w3.org/1999/xlink">n</italic>
###xml 702 723 700 719 <td xmlns:xlink="http://www.w3.org/1999/xlink">1.24&#8201;&#177;&#8201;0.30 (<italic>n</italic>&#8201;=&#8201;3)</td>
###xml 695 723 693 719 <tr xmlns:xlink="http://www.w3.org/1999/xlink"><td><italic>Pten</italic><sup>+/+</sup></td><td>1.24&#8201;&#177;&#8201;0.30 (<italic>n</italic>&#8201;=&#8201;3)</td></tr>
###xml 723 727 719 723 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Pten</italic>
###xml 727 730 723 726 <sup xmlns:xlink="http://www.w3.org/1999/xlink">+/&#8722;</sup>
###xml 723 730 719 726 <td xmlns:xlink="http://www.w3.org/1999/xlink"><italic>Pten</italic><sup>+/&#8722;</sup></td>
###xml 745 746 739 740 <italic xmlns:xlink="http://www.w3.org/1999/xlink">n</italic>
###xml 730 751 726 745 <td xmlns:xlink="http://www.w3.org/1999/xlink">1.29&#8201;&#177;&#8201;0.15 (<italic>n</italic>&#8201;=&#8201;3)</td>
###xml 723 751 719 745 <tr xmlns:xlink="http://www.w3.org/1999/xlink"><td><italic>Pten</italic><sup>+/&#8722;</sup></td><td>1.29&#8201;&#177;&#8201;0.15 (<italic>n</italic>&#8201;=&#8201;3)</td></tr>
###xml 695 751 693 745 <tbody xmlns:xlink="http://www.w3.org/1999/xlink"><tr><td><italic>Pten</italic><sup>+/+</sup></td><td>1.24&#8201;&#177;&#8201;0.30 (<italic>n</italic>&#8201;=&#8201;3)</td></tr><tr><td><italic>Pten</italic><sup>+/&#8722;</sup></td><td>1.29&#8201;&#177;&#8201;0.15 (<italic>n</italic>&#8201;=&#8201;3)</td></tr></tbody>
###xml 665 751 665 745 <table xmlns:xlink="http://www.w3.org/1999/xlink" frame="hsides" rules="groups"><thead><tr><th>&#160;</th><th>Mean beta cell mass&#177;SE (mg)</th></tr></thead><tbody><tr><td><italic>Pten</italic><sup>+/+</sup></td><td>1.24&#8201;&#177;&#8201;0.30 (<italic>n</italic>&#8201;=&#8201;3)</td></tr><tr><td><italic>Pten</italic><sup>+/&#8722;</sup></td><td>1.29&#8201;&#177;&#8201;0.15 (<italic>n</italic>&#8201;=&#8201;3)</td></tr></tbody></table>
###xml 598 751 598 745 <table-wrap xmlns:xlink="http://www.w3.org/1999/xlink" id="Tab3"><label>Table&#160;3</label><caption><p textid="34">Pancreatic beta cell mass of <italic>Pten</italic><sup>+/+</sup> and <italic>Pten</italic><sup>+/&#8722;</sup> littermates</p></caption><table frame="hsides" rules="groups"><thead><tr><th>&#160;</th><th>Mean beta cell mass&#177;SE (mg)</th></tr></thead><tbody><tr><td><italic>Pten</italic><sup>+/+</sup></td><td>1.24&#8201;&#177;&#8201;0.30 (<italic>n</italic>&#8201;=&#8201;3)</td></tr><tr><td><italic>Pten</italic><sup>+/&#8722;</sup></td><td>1.29&#8201;&#177;&#8201;0.15 (<italic>n</italic>&#8201;=&#8201;3)</td></tr></tbody></table></table-wrap>
###xml 105 109 <span type="species:ncbi:10090">mice</span>
###xml 299 303 <span type="species:ncbi:10090">mice</span>
###xml 446 450 <span type="species:ncbi:10090">mice</span>
Immunofluorescence of pancreatic sections revealed similar morphology of islets of wild-type and Pten+/- mice (Fig. 2), suggesting Pten haploinsufficiency has no marked effect on islet morphology. Accordingly, beta cell mass was not found to be significantly different between wild-type and Pten+/- mice (Table 3). Fig. 2Pancreatic islet morphology and immunohistochemistry for insulin (green) and glucagon (red) in wild-type (a) and Pten+/- (b) mice. Pancreatic sections were immunostained as described in Materials and methods and visualised by fluorescence microscopy. Original magnification x40Table 3Pancreatic beta cell mass of Pten+/+ and Pten+/- littermates Mean beta cell mass+/-SE (mg)Pten+/+1.24 +/- 0.30 (n = 3)Pten+/-1.29 +/- 0.15 (n = 3)
###end p 32
###begin p 33
###xml 66 71 66 71 <italic xmlns:xlink="http://www.w3.org/1999/xlink">green</italic>
###xml 87 90 87 90 <italic xmlns:xlink="http://www.w3.org/1999/xlink">red</italic>
###xml 106 107 106 107 <bold xmlns:xlink="http://www.w3.org/1999/xlink">a</bold>
###xml 113 117 113 117 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Pten</italic>
###xml 117 120 117 120 <sup xmlns:xlink="http://www.w3.org/1999/xlink">+/&#8722;</sup>
###xml 122 123 122 123 <bold xmlns:xlink="http://www.w3.org/1999/xlink">b</bold>
###xml 186 207 186 207 <xref xmlns:xlink="http://www.w3.org/1999/xlink" rid="Sec2" ref-type="sec">Materials and methods</xref>
###xml 125 129 <span type="species:ncbi:10090">mice</span>
Pancreatic islet morphology and immunohistochemistry for insulin (green) and glucagon (red) in wild-type (a) and Pten+/- (b) mice. Pancreatic sections were immunostained as described in Materials and methods and visualised by fluorescence microscopy. Original magnification x40
###end p 33
###begin p 34
###xml 29 33 29 33 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Pten</italic>
###xml 33 36 33 36 <sup xmlns:xlink="http://www.w3.org/1999/xlink">+/+</sup>
###xml 41 45 41 45 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Pten</italic>
###xml 45 48 45 48 <sup xmlns:xlink="http://www.w3.org/1999/xlink">+/&#8722;</sup>
Pancreatic beta cell mass of Pten+/+ and Pten+/- littermates
###end p 34
###begin p 35
###xml 86 88 86 88 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="CR10">10</xref>
###xml 90 92 90 92 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="CR20">20</xref>
###xml 161 163 161 163 <sup xmlns:xlink="http://www.w3.org/1999/xlink">18</sup>
###xml 201 203 201 203 <sup xmlns:xlink="http://www.w3.org/1999/xlink">18</sup>
###xml 367 369 367 369 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="CR21">21</xref>
###xml 434 438 434 438 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Pten</italic>
###xml 438 441 438 441 <sup xmlns:xlink="http://www.w3.org/1999/xlink">+/&#8722;</sup>
###xml 565 567 565 567 <sup xmlns:xlink="http://www.w3.org/1999/xlink">18</sup>
###xml 611 613 611 613 <sup xmlns:xlink="http://www.w3.org/1999/xlink">18</sup>
###xml 659 660 659 660 <xref xmlns:xlink="http://www.w3.org/1999/xlink" rid="Fig3" ref-type="fig">3</xref>
###xml 664 666 664 666 <sup xmlns:xlink="http://www.w3.org/1999/xlink">18</sup>
###xml 775 779 775 779 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Pten</italic>
###xml 779 782 779 782 <sup xmlns:xlink="http://www.w3.org/1999/xlink">+/&#8722;</sup>
###xml 831 832 831 832 <xref xmlns:xlink="http://www.w3.org/1999/xlink" rid="Fig3" ref-type="fig">3</xref>
###xml 836 842 836 842 <label xmlns:xlink="http://www.w3.org/1999/xlink">Fig.&#160;3</label>
###xml 871 873 871 873 <sup xmlns:xlink="http://www.w3.org/1999/xlink">18</sup>
###xml 894 898 894 898 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Pten</italic>
###xml 898 901 898 901 <sup xmlns:xlink="http://www.w3.org/1999/xlink">+/&#8722;</sup>
###xml 1055 1057 1055 1057 <sup xmlns:xlink="http://www.w3.org/1999/xlink">18</sup>
###xml 1109 1111 1109 1111 <sup xmlns:xlink="http://www.w3.org/1999/xlink">18</sup>
###xml 1242 1245 1242 1245 <bold xmlns:xlink="http://www.w3.org/1999/xlink">a&#8211;f</bold>
###xml 1257 1259 1257 1259 <sup xmlns:xlink="http://www.w3.org/1999/xlink">18</sup>
###xml 1331 1335 1331 1335 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Pten</italic>
###xml 1335 1338 1335 1338 <sup xmlns:xlink="http://www.w3.org/1999/xlink">+/&#8722;</sup>
###xml 1362 1363 1362 1363 <bold xmlns:xlink="http://www.w3.org/1999/xlink">a</bold>
###xml 1371 1372 1371 1372 <bold xmlns:xlink="http://www.w3.org/1999/xlink">b</bold>
###xml 1381 1382 1381 1382 <bold xmlns:xlink="http://www.w3.org/1999/xlink">c</bold>
###xml 1391 1392 1391 1392 <bold xmlns:xlink="http://www.w3.org/1999/xlink">d</bold>
###xml 1401 1402 1401 1402 <bold xmlns:xlink="http://www.w3.org/1999/xlink">e</bold>
###xml 1411 1412 1411 1412 <bold xmlns:xlink="http://www.w3.org/1999/xlink">f</bold>
###xml 1484 1486 1484 1486 <sup xmlns:xlink="http://www.w3.org/1999/xlink">18</sup>
###xml 1595 1616 1595 1616 <xref xmlns:xlink="http://www.w3.org/1999/xlink" rid="Sec2" ref-type="sec">Materials and methods</xref>
###xml 1618 1619 1618 1619 <bold xmlns:xlink="http://www.w3.org/1999/xlink">g</bold>
###xml 1657 1659 1657 1659 <sup xmlns:xlink="http://www.w3.org/1999/xlink">18</sup>
###xml 1705 1707 1705 1707 <sup xmlns:xlink="http://www.w3.org/1999/xlink">18</sup>
###xml 1788 1795 1788 1795 <italic xmlns:xlink="http://www.w3.org/1999/xlink">circles</italic>
###xml 1801 1805 1801 1805 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Pten</italic>
###xml 1805 1808 1805 1808 <sup xmlns:xlink="http://www.w3.org/1999/xlink">+/&#8722;</sup>
###xml 1815 1824 1815 1824 <italic xmlns:xlink="http://www.w3.org/1999/xlink">triangles</italic>
###xml 1838 1839 1836 1837 <italic xmlns:xlink="http://www.w3.org/1999/xlink">n</italic>
###xml 842 1854 842 1852 <p xmlns:xlink="http://www.w3.org/1999/xlink" textid="36">Insulin-stimulated uptake of <sup>18</sup>FDG in wild-type and <italic>Pten</italic><sup>+/&#8722;</sup> mice. Mice were fasted for 15&#160;h prior to i.p. injection of 0.6&#160;mU insulin/g body weight. Twenty&#160;minutes after insulin injection, mice were injected with <sup>18</sup>FDG via a tail vein, and whole-body distribution of <sup>18</sup>FDG was monitored by microPET for 60&#160;min. The experiment was repeated three times with similar results. Typical results are shown. <bold>a&#8211;f</bold> Imaging of <sup>18</sup>FDG distribution in coronal section; wild-type mouse is on the left and <italic>Pten</italic><sup>+/&#8722;</sup> mouse is on the right (<bold>a</bold> 5&#160;min; <bold>b</bold> 15&#160;min; <bold>c</bold> 25&#160;min; <bold>d</bold> 35&#160;min; <bold>e</bold> 45&#160;min; <bold>f</bold> 55&#160;min). Hindlimb muscles were highlighted as regions of interest, and <sup>18</sup>FDG activity in each region of interest quantified across coronal planes at each time-point, as described in <xref rid="Sec2" ref-type="sec">Materials and methods</xref>. <bold>g</bold> Graphical representation of relative <sup>18</sup>FDG activity. Data are shown as proportion of <sup>18</sup>FDG activity in hindlimbs relative to activity in whole body for wild-type mice (<italic>circles</italic>) and <italic>Pten</italic><sup>+/&#8722;</sup> mice (<italic>triangles</italic>) (mean&#177;SD; <italic>n</italic>&#8201;=&#8201;3 per point)</p>
###xml 842 1854 842 1852 <caption xmlns:xlink="http://www.w3.org/1999/xlink"><p textid="36">Insulin-stimulated uptake of <sup>18</sup>FDG in wild-type and <italic>Pten</italic><sup>+/&#8722;</sup> mice. Mice were fasted for 15&#160;h prior to i.p. injection of 0.6&#160;mU insulin/g body weight. Twenty&#160;minutes after insulin injection, mice were injected with <sup>18</sup>FDG via a tail vein, and whole-body distribution of <sup>18</sup>FDG was monitored by microPET for 60&#160;min. The experiment was repeated three times with similar results. Typical results are shown. <bold>a&#8211;f</bold> Imaging of <sup>18</sup>FDG distribution in coronal section; wild-type mouse is on the left and <italic>Pten</italic><sup>+/&#8722;</sup> mouse is on the right (<bold>a</bold> 5&#160;min; <bold>b</bold> 15&#160;min; <bold>c</bold> 25&#160;min; <bold>d</bold> 35&#160;min; <bold>e</bold> 45&#160;min; <bold>f</bold> 55&#160;min). Hindlimb muscles were highlighted as regions of interest, and <sup>18</sup>FDG activity in each region of interest quantified across coronal planes at each time-point, as described in <xref rid="Sec2" ref-type="sec">Materials and methods</xref>. <bold>g</bold> Graphical representation of relative <sup>18</sup>FDG activity. Data are shown as proportion of <sup>18</sup>FDG activity in hindlimbs relative to activity in whole body for wild-type mice (<italic>circles</italic>) and <italic>Pten</italic><sup>+/&#8722;</sup> mice (<italic>triangles</italic>) (mean&#177;SD; <italic>n</italic>&#8201;=&#8201;3 per point)</p></caption>
###xml 1854 1854 1852 1852 <graphic xmlns:xlink="http://www.w3.org/1999/xlink" position="anchor" xlink:href="125_2006_531_Fig3_HTML" id="MO3"/>
###xml 836 1854 836 1852 <fig xmlns:xlink="http://www.w3.org/1999/xlink" id="Fig3"><label>Fig.&#160;3</label><caption><p textid="36">Insulin-stimulated uptake of <sup>18</sup>FDG in wild-type and <italic>Pten</italic><sup>+/&#8722;</sup> mice. Mice were fasted for 15&#160;h prior to i.p. injection of 0.6&#160;mU insulin/g body weight. Twenty&#160;minutes after insulin injection, mice were injected with <sup>18</sup>FDG via a tail vein, and whole-body distribution of <sup>18</sup>FDG was monitored by microPET for 60&#160;min. The experiment was repeated three times with similar results. Typical results are shown. <bold>a&#8211;f</bold> Imaging of <sup>18</sup>FDG distribution in coronal section; wild-type mouse is on the left and <italic>Pten</italic><sup>+/&#8722;</sup> mouse is on the right (<bold>a</bold> 5&#160;min; <bold>b</bold> 15&#160;min; <bold>c</bold> 25&#160;min; <bold>d</bold> 35&#160;min; <bold>e</bold> 45&#160;min; <bold>f</bold> 55&#160;min). Hindlimb muscles were highlighted as regions of interest, and <sup>18</sup>FDG activity in each region of interest quantified across coronal planes at each time-point, as described in <xref rid="Sec2" ref-type="sec">Materials and methods</xref>. <bold>g</bold> Graphical representation of relative <sup>18</sup>FDG activity. Data are shown as proportion of <sup>18</sup>FDG activity in hindlimbs relative to activity in whole body for wild-type mice (<italic>circles</italic>) and <italic>Pten</italic><sup>+/&#8722;</sup> mice (<italic>triangles</italic>) (mean&#177;SD; <italic>n</italic>&#8201;=&#8201;3 per point)</p></caption><graphic position="anchor" xlink:href="125_2006_531_Fig3_HTML" id="MO3"/></fig>
###xml 442 446 <span type="species:ncbi:10090">mice</span>
###xml 452 456 <span type="species:ncbi:10090">mice</span>
###xml 590 594 <span type="species:ncbi:10090">Mice</span>
###xml 801 805 <span type="species:ncbi:10090">mice</span>
###xml 902 906 <span type="species:ncbi:10090">mice</span>
###xml 908 912 <span type="species:ncbi:10090">Mice</span>
###xml 1031 1035 <span type="species:ncbi:10090">mice</span>
###xml 1306 1311 <span type="species:ncbi:10090">mouse</span>
###xml 1339 1344 <span type="species:ncbi:10090">mouse</span>
###xml 1782 1786 <span type="species:ncbi:10090">mice</span>
###xml 1809 1813 <span type="species:ncbi:10090">mice</span>
Skeletal muscle is an important tissue involved in insulin-stimulated glucose uptake [10, 20]. In vivo glucose uptake was assessed by monitoring distribution of 18FDG into muscles in real-time by PET. 18FDG is transported into cells by glucose transporters and is phosphorylated by hexokinase, but is not a substrate for further metabolism in the glycolytic pathway [21]. To compare insulin-stimulated glucose uptake in wild-type and Pten+/- mice, the mice were fasted for 15 h, then injected i.p. with insulin (0.6 mU/g body weight) 20 min prior to injection with 18FDG via the tail vein. Mice were imaged for 18FDG uptake into the hindlimb for 60 min (Fig. 3a). 18FDG activity in hindlimbs was analysed as a proportion of total body activity, and was found to be higher in Pten+/- than in wild-type mice at all time-points (Fig. 3b). Fig. 3Insulin-stimulated uptake of 18FDG in wild-type and Pten+/- mice. Mice were fasted for 15 h prior to i.p. injection of 0.6 mU insulin/g body weight. Twenty minutes after insulin injection, mice were injected with 18FDG via a tail vein, and whole-body distribution of 18FDG was monitored by microPET for 60 min. The experiment was repeated three times with similar results. Typical results are shown. a-f Imaging of 18FDG distribution in coronal section; wild-type mouse is on the left and Pten+/- mouse is on the right (a 5 min; b 15 min; c 25 min; d 35 min; e 45 min; f 55 min). Hindlimb muscles were highlighted as regions of interest, and 18FDG activity in each region of interest quantified across coronal planes at each time-point, as described in Materials and methods. g Graphical representation of relative 18FDG activity. Data are shown as proportion of 18FDG activity in hindlimbs relative to activity in whole body for wild-type mice (circles) and Pten+/- mice (triangles) (mean+/-SD; n = 3 per point)
###end p 35
###begin p 36
###xml 29 31 29 31 <sup xmlns:xlink="http://www.w3.org/1999/xlink">18</sup>
###xml 52 56 52 56 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Pten</italic>
###xml 56 59 56 59 <sup xmlns:xlink="http://www.w3.org/1999/xlink">+/&#8722;</sup>
###xml 213 215 213 215 <sup xmlns:xlink="http://www.w3.org/1999/xlink">18</sup>
###xml 267 269 267 269 <sup xmlns:xlink="http://www.w3.org/1999/xlink">18</sup>
###xml 400 403 400 403 <bold xmlns:xlink="http://www.w3.org/1999/xlink">a&#8211;f</bold>
###xml 415 417 415 417 <sup xmlns:xlink="http://www.w3.org/1999/xlink">18</sup>
###xml 489 493 489 493 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Pten</italic>
###xml 493 496 493 496 <sup xmlns:xlink="http://www.w3.org/1999/xlink">+/&#8722;</sup>
###xml 520 521 520 521 <bold xmlns:xlink="http://www.w3.org/1999/xlink">a</bold>
###xml 529 530 529 530 <bold xmlns:xlink="http://www.w3.org/1999/xlink">b</bold>
###xml 539 540 539 540 <bold xmlns:xlink="http://www.w3.org/1999/xlink">c</bold>
###xml 549 550 549 550 <bold xmlns:xlink="http://www.w3.org/1999/xlink">d</bold>
###xml 559 560 559 560 <bold xmlns:xlink="http://www.w3.org/1999/xlink">e</bold>
###xml 569 570 569 570 <bold xmlns:xlink="http://www.w3.org/1999/xlink">f</bold>
###xml 642 644 642 644 <sup xmlns:xlink="http://www.w3.org/1999/xlink">18</sup>
###xml 753 774 753 774 <xref xmlns:xlink="http://www.w3.org/1999/xlink" rid="Sec2" ref-type="sec">Materials and methods</xref>
###xml 776 777 776 777 <bold xmlns:xlink="http://www.w3.org/1999/xlink">g</bold>
###xml 815 817 815 817 <sup xmlns:xlink="http://www.w3.org/1999/xlink">18</sup>
###xml 863 865 863 865 <sup xmlns:xlink="http://www.w3.org/1999/xlink">18</sup>
###xml 946 953 946 953 <italic xmlns:xlink="http://www.w3.org/1999/xlink">circles</italic>
###xml 959 963 959 963 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Pten</italic>
###xml 963 966 963 966 <sup xmlns:xlink="http://www.w3.org/1999/xlink">+/&#8722;</sup>
###xml 973 982 973 982 <italic xmlns:xlink="http://www.w3.org/1999/xlink">triangles</italic>
###xml 996 997 994 995 <italic xmlns:xlink="http://www.w3.org/1999/xlink">n</italic>
###xml 60 64 <span type="species:ncbi:10090">mice</span>
###xml 66 70 <span type="species:ncbi:10090">Mice</span>
###xml 189 193 <span type="species:ncbi:10090">mice</span>
###xml 464 469 <span type="species:ncbi:10090">mouse</span>
###xml 497 502 <span type="species:ncbi:10090">mouse</span>
###xml 940 944 <span type="species:ncbi:10090">mice</span>
###xml 967 971 <span type="species:ncbi:10090">mice</span>
Insulin-stimulated uptake of 18FDG in wild-type and Pten+/- mice. Mice were fasted for 15 h prior to i.p. injection of 0.6 mU insulin/g body weight. Twenty minutes after insulin injection, mice were injected with 18FDG via a tail vein, and whole-body distribution of 18FDG was monitored by microPET for 60 min. The experiment was repeated three times with similar results. Typical results are shown. a-f Imaging of 18FDG distribution in coronal section; wild-type mouse is on the left and Pten+/- mouse is on the right (a 5 min; b 15 min; c 25 min; d 35 min; e 45 min; f 55 min). Hindlimb muscles were highlighted as regions of interest, and 18FDG activity in each region of interest quantified across coronal planes at each time-point, as described in Materials and methods. g Graphical representation of relative 18FDG activity. Data are shown as proportion of 18FDG activity in hindlimbs relative to activity in whole body for wild-type mice (circles) and Pten+/- mice (triangles) (mean+/-SD; n = 3 per point)
###end p 36
###begin p 37
###xml 13 17 13 17 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Pten</italic>
###xml 17 20 17 20 <sup xmlns:xlink="http://www.w3.org/1999/xlink">+/&#8722;</sup>
###xml 104 106 104 106 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="CR14">14</xref>
###xml 108 110 108 110 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="CR22">22</xref>
###xml 111 113 111 113 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="CR24">24</xref>
###xml 266 270 266 270 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Pten</italic>
###xml 270 273 270 273 <sup xmlns:xlink="http://www.w3.org/1999/xlink">+/&#8722;</sup>
###xml 318 322 318 322 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Pten</italic>
###xml 322 325 322 325 <sup xmlns:xlink="http://www.w3.org/1999/xlink">+/&#8722;</sup>
###xml 356 357 356 357 <sup xmlns:xlink="http://www.w3.org/1999/xlink">3</sup>
###xml 492 493 492 493 <xref xmlns:xlink="http://www.w3.org/1999/xlink" rid="Fig4" ref-type="fig">4</xref>
###xml 559 563 559 563 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Pten</italic>
###xml 563 566 563 566 <sup xmlns:xlink="http://www.w3.org/1999/xlink">+/&#8722;</sup>
###xml 636 640 636 640 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Pten</italic>
###xml 640 643 640 643 <sup xmlns:xlink="http://www.w3.org/1999/xlink">+/&#8722;</sup>
###xml 681 685 681 685 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Pten</italic>
###xml 685 688 685 688 <sup xmlns:xlink="http://www.w3.org/1999/xlink">+/&#8722;</sup>
###xml 890 892 890 892 <sup xmlns:xlink="http://www.w3.org/1999/xlink">18</sup>
###xml 962 966 962 966 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Pten</italic>
###xml 987 993 987 993 <label xmlns:xlink="http://www.w3.org/1999/xlink">Fig.&#160;4</label>
###xml 993 994 993 994 <bold xmlns:xlink="http://www.w3.org/1999/xlink">a</bold>
###xml 1003 1004 1003 1004 <sup xmlns:xlink="http://www.w3.org/1999/xlink">3</sup>
###xml 1038 1042 1038 1042 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Pten</italic>
###xml 1042 1045 1042 1045 <sup xmlns:xlink="http://www.w3.org/1999/xlink">+/&#8722;</sup>
###xml 1137 1138 1136 1137 <sup xmlns:xlink="http://www.w3.org/1999/xlink">3</sup>
###xml 1402 1415 1397 1410 <italic xmlns:xlink="http://www.w3.org/1999/xlink">White circles</italic>
###xml 1452 1465 1446 1459 <italic xmlns:xlink="http://www.w3.org/1999/xlink">black circles</italic>
###xml 1502 1517 1495 1510 <italic xmlns:xlink="http://www.w3.org/1999/xlink">white triangles</italic>
###xml 1519 1523 1512 1516 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Pten</italic>
###xml 1523 1526 1516 1519 <sup xmlns:xlink="http://www.w3.org/1999/xlink">+/&#8722;</sup>
###xml 1552 1567 1544 1559 <italic xmlns:xlink="http://www.w3.org/1999/xlink">black triangles</italic>
###xml 1569 1573 1561 1565 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Pten</italic>
###xml 1573 1576 1565 1568 <sup xmlns:xlink="http://www.w3.org/1999/xlink">+/&#8722;</sup>
###xml 1602 1603 1593 1594 <bold xmlns:xlink="http://www.w3.org/1999/xlink">b</bold>
###xml 1703 1705 1694 1696 <italic xmlns:xlink="http://www.w3.org/1999/xlink">WT</italic>
###xml 1711 1715 1702 1706 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Pten</italic>
###xml 1715 1718 1706 1709 <sup xmlns:xlink="http://www.w3.org/1999/xlink">+/&#8722;</sup>
###xml 1757 1778 1748 1769 <xref xmlns:xlink="http://www.w3.org/1999/xlink" rid="Sec2" ref-type="sec">Materials and methods</xref>
###xml 993 1778 993 1769 <p xmlns:xlink="http://www.w3.org/1999/xlink" textid="38"><bold>a</bold> 2-Deoxy[<sup>3</sup>H]glucose uptake in wild-type and <italic>Pten</italic><sup>+/&#8722;</sup> myocytes. Myocytes were serum-starved for 12&#160;h prior to incubation with 10&#160;&#956;mol/l 2-deoxy[<sup>3</sup>H]glucose (0.037&#160;MBq/&#956;mol/l) for the indicated times with 0 or 1&#160;&#956;mol/l insulin. Following incubation cells were lysed and aliquots of lysates were taken for determination of radioactivity by scintillation counting. Means&#177;SD for three separate determinations. <italic>White circles</italic>, wild-type cells 0&#160;&#956;mol/l insulin; <italic>black circles</italic>, wild-type cells 1&#160;&#956;mol/l insulin; <italic>white triangles</italic>, <italic>Pten</italic><sup>+/&#8722;</sup> cells 0&#160;&#956;mol/l insulin; <italic>black triangles</italic>, <italic>Pten</italic><sup>+/&#8722;</sup> cells 1&#160;&#956;mol/l insulin. <bold>b</bold> Cell-surface GLUT1 and GLUT4 levels. Levels of cell-surface GLUT1 and GLUT4 proteins in wild-type (<italic>WT</italic>) and <italic>Pten</italic><sup>+/&#8722;</sup> cells were determined as described in <xref rid="Sec2" ref-type="sec">Materials and methods</xref></p>
###xml 993 1778 993 1769 <caption xmlns:xlink="http://www.w3.org/1999/xlink"><p textid="38"><bold>a</bold> 2-Deoxy[<sup>3</sup>H]glucose uptake in wild-type and <italic>Pten</italic><sup>+/&#8722;</sup> myocytes. Myocytes were serum-starved for 12&#160;h prior to incubation with 10&#160;&#956;mol/l 2-deoxy[<sup>3</sup>H]glucose (0.037&#160;MBq/&#956;mol/l) for the indicated times with 0 or 1&#160;&#956;mol/l insulin. Following incubation cells were lysed and aliquots of lysates were taken for determination of radioactivity by scintillation counting. Means&#177;SD for three separate determinations. <italic>White circles</italic>, wild-type cells 0&#160;&#956;mol/l insulin; <italic>black circles</italic>, wild-type cells 1&#160;&#956;mol/l insulin; <italic>white triangles</italic>, <italic>Pten</italic><sup>+/&#8722;</sup> cells 0&#160;&#956;mol/l insulin; <italic>black triangles</italic>, <italic>Pten</italic><sup>+/&#8722;</sup> cells 1&#160;&#956;mol/l insulin. <bold>b</bold> Cell-surface GLUT1 and GLUT4 levels. Levels of cell-surface GLUT1 and GLUT4 proteins in wild-type (<italic>WT</italic>) and <italic>Pten</italic><sup>+/&#8722;</sup> cells were determined as described in <xref rid="Sec2" ref-type="sec">Materials and methods</xref></p></caption>
###xml 1778 1778 1769 1769 <graphic xmlns:xlink="http://www.w3.org/1999/xlink" position="anchor" xlink:href="125_2006_531_Fig4_HTML" id="MO4"/>
###xml 987 1778 987 1769 <fig xmlns:xlink="http://www.w3.org/1999/xlink" id="Fig4"><label>Fig.&#160;4</label><caption><p textid="38"><bold>a</bold> 2-Deoxy[<sup>3</sup>H]glucose uptake in wild-type and <italic>Pten</italic><sup>+/&#8722;</sup> myocytes. Myocytes were serum-starved for 12&#160;h prior to incubation with 10&#160;&#956;mol/l 2-deoxy[<sup>3</sup>H]glucose (0.037&#160;MBq/&#956;mol/l) for the indicated times with 0 or 1&#160;&#956;mol/l insulin. Following incubation cells were lysed and aliquots of lysates were taken for determination of radioactivity by scintillation counting. Means&#177;SD for three separate determinations. <italic>White circles</italic>, wild-type cells 0&#160;&#956;mol/l insulin; <italic>black circles</italic>, wild-type cells 1&#160;&#956;mol/l insulin; <italic>white triangles</italic>, <italic>Pten</italic><sup>+/&#8722;</sup> cells 0&#160;&#956;mol/l insulin; <italic>black triangles</italic>, <italic>Pten</italic><sup>+/&#8722;</sup> cells 1&#160;&#956;mol/l insulin. <bold>b</bold> Cell-surface GLUT1 and GLUT4 levels. Levels of cell-surface GLUT1 and GLUT4 proteins in wild-type (<italic>WT</italic>) and <italic>Pten</italic><sup>+/&#8722;</sup> cells were determined as described in <xref rid="Sec2" ref-type="sec">Materials and methods</xref></p></caption><graphic position="anchor" xlink:href="125_2006_531_Fig4_HTML" id="MO4"/></fig>
###xml 21 25 <span type="species:ncbi:10090">mice</span>
###xml 98 102 <span type="species:ncbi:10090">mice</span>
###xml 274 278 <span type="species:ncbi:10090">mice</span>
###xml 326 330 <span type="species:ncbi:10090">mice</span>
###xml 567 571 <span type="species:ncbi:10090">mice</span>
Tissues from Pten+/- mice exhibited slightly reduced levels of Pten protein relative to wild-type mice [14, 22-24]. In order to examine cellular glucose uptake and intracellular signalling events, primary myocytes were cultured from hindlimb muscle of wild-type and Pten+/- mice. In the absence of insulin, cells from Pten+/- mice showed increased 2-deoxy[3H]glucose uptake at all time-points measured, to a maximum increase of twofold relative to wild-type cells at the 3 h time-point (Fig. 4a). This result, together with the lower fasting glucose level of Pten+/- mice, suggest that the PI3K/PKB pathway was chronically activated in Pten+/- animals. In the presence of insulin, Pten+/- cells exhibited a further increase in glucose uptake, up to threefold greater than wild-type cells. This observation is consistent with the above results of the insulin and glucose challenge tests and 18FDG uptake experiment in showing a hypersensitivity to insulin due to Pten haploinsufficiency. Fig. 4a 2-Deoxy[3H]glucose uptake in wild-type and Pten+/- myocytes. Myocytes were serum-starved for 12 h prior to incubation with 10 mumol/l 2-deoxy[3H]glucose (0.037 MBq/mumol/l) for the indicated times with 0 or 1 mumol/l insulin. Following incubation cells were lysed and aliquots of lysates were taken for determination of radioactivity by scintillation counting. Means+/-SD for three separate determinations. White circles, wild-type cells 0 mumol/l insulin; black circles, wild-type cells 1 mumol/l insulin; white triangles, Pten+/- cells 0 mumol/l insulin; black triangles, Pten+/- cells 1 mumol/l insulin. b Cell-surface GLUT1 and GLUT4 levels. Levels of cell-surface GLUT1 and GLUT4 proteins in wild-type (WT) and Pten+/- cells were determined as described in Materials and methods
###end p 37
###begin p 38
###xml 0 1 0 1 <bold xmlns:xlink="http://www.w3.org/1999/xlink">a</bold>
###xml 10 11 10 11 <sup xmlns:xlink="http://www.w3.org/1999/xlink">3</sup>
###xml 45 49 45 49 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Pten</italic>
###xml 49 52 49 52 <sup xmlns:xlink="http://www.w3.org/1999/xlink">+/&#8722;</sup>
###xml 144 145 143 144 <sup xmlns:xlink="http://www.w3.org/1999/xlink">3</sup>
###xml 409 422 404 417 <italic xmlns:xlink="http://www.w3.org/1999/xlink">White circles</italic>
###xml 459 472 453 466 <italic xmlns:xlink="http://www.w3.org/1999/xlink">black circles</italic>
###xml 509 524 502 517 <italic xmlns:xlink="http://www.w3.org/1999/xlink">white triangles</italic>
###xml 526 530 519 523 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Pten</italic>
###xml 530 533 523 526 <sup xmlns:xlink="http://www.w3.org/1999/xlink">+/&#8722;</sup>
###xml 559 574 551 566 <italic xmlns:xlink="http://www.w3.org/1999/xlink">black triangles</italic>
###xml 576 580 568 572 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Pten</italic>
###xml 580 583 572 575 <sup xmlns:xlink="http://www.w3.org/1999/xlink">+/&#8722;</sup>
###xml 609 610 600 601 <bold xmlns:xlink="http://www.w3.org/1999/xlink">b</bold>
###xml 710 712 701 703 <italic xmlns:xlink="http://www.w3.org/1999/xlink">WT</italic>
###xml 718 722 709 713 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Pten</italic>
###xml 722 725 713 716 <sup xmlns:xlink="http://www.w3.org/1999/xlink">+/&#8722;</sup>
###xml 764 785 755 776 <xref xmlns:xlink="http://www.w3.org/1999/xlink" rid="Sec2" ref-type="sec">Materials and methods</xref>
a 2-Deoxy[3H]glucose uptake in wild-type and Pten+/- myocytes. Myocytes were serum-starved for 12 h prior to incubation with 10 mumol/l 2-deoxy[3H]glucose (0.037 MBq/mumol/l) for the indicated times with 0 or 1 mumol/l insulin. Following incubation cells were lysed and aliquots of lysates were taken for determination of radioactivity by scintillation counting. Means+/-SD for three separate determinations. White circles, wild-type cells 0 mumol/l insulin; black circles, wild-type cells 1 mumol/l insulin; white triangles, Pten+/- cells 0 mumol/l insulin; black triangles, Pten+/- cells 1 mumol/l insulin. b Cell-surface GLUT1 and GLUT4 levels. Levels of cell-surface GLUT1 and GLUT4 proteins in wild-type (WT) and Pten+/- cells were determined as described in Materials and methods
###end p 38
###begin p 39
###xml 288 290 288 290 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="CR25">25</xref>
###xml 307 308 307 308 <sup xmlns:xlink="http://www.w3.org/1999/xlink">3</sup>
###xml 341 345 341 345 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Pten</italic>
###xml 345 348 345 348 <sup xmlns:xlink="http://www.w3.org/1999/xlink">+/&#8722;</sup>
###xml 392 393 392 393 <xref xmlns:xlink="http://www.w3.org/1999/xlink" rid="Fig4" ref-type="fig">4</xref>
###xml 504 505 504 505 <xref xmlns:xlink="http://www.w3.org/1999/xlink" rid="Fig4" ref-type="fig">4</xref>
###xml 569 573 569 573 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Pten</italic>
###xml 573 576 573 576 <sup xmlns:xlink="http://www.w3.org/1999/xlink">+/&#8722;</sup>
Glucose transport into skeletal muscle occurs by a facilitated diffusion process mediated primarily by the glucose transporter proteins, GLUT1 and GLUT4. The level of GLUT4 at the plasma membrane is tightly regulated by insulin, whereas GLUT1 is found constitutively on the cell surface [25]. Since 2-deoxy[3H]glucose uptake was elevated in Pten+/- cells even in the absence of insulin (Fig. 4a), we analysed cell-surface GLUT4 and GLUT1 by western immunoblot as described in Materials and methods (Fig. 4b). This analysis showed increased GLUT4 at the cell surface in Pten+/- cells, while similar GLUT1 levels were observed in the two cell types.
###end p 39
###begin p 40
###xml 170 172 170 172 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="CR26">26</xref>
###xml 174 176 174 176 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="CR27">27</xref>
###xml 244 248 244 248 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Pten</italic>
###xml 248 251 248 251 <sup xmlns:xlink="http://www.w3.org/1999/xlink">+/&#8722;</sup>
###xml 405 406 405 406 <xref xmlns:xlink="http://www.w3.org/1999/xlink" rid="Fig5" ref-type="fig">5</xref>
###xml 547 551 547 551 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Pten</italic>
###xml 551 554 551 554 <sup xmlns:xlink="http://www.w3.org/1999/xlink">+/&#8722;</sup>
###xml 689 693 689 693 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Pten</italic>
###xml 693 696 693 696 <sup xmlns:xlink="http://www.w3.org/1999/xlink">+/&#8722;</sup>
###xml 701 705 701 705 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Pten</italic>
###xml 705 708 705 708 <sup xmlns:xlink="http://www.w3.org/1999/xlink">+/+</sup>
###xml 721 722 721 722 <xref xmlns:xlink="http://www.w3.org/1999/xlink" rid="Fig5" ref-type="fig">5</xref>
###xml 1093 1097 1090 1094 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Pten</italic>
###xml 1097 1100 1094 1097 <sup xmlns:xlink="http://www.w3.org/1999/xlink">+/&#8722;</sup>
###xml 1198 1202 1192 1196 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Pten</italic>
###xml 1202 1205 1196 1199 <sup xmlns:xlink="http://www.w3.org/1999/xlink">+/+</sup>
###xml 1218 1219 1212 1213 <xref xmlns:xlink="http://www.w3.org/1999/xlink" rid="Fig5" ref-type="fig">5</xref>
###xml 1222 1228 1216 1222 <label xmlns:xlink="http://www.w3.org/1999/xlink">Fig.&#160;5</label>
###xml 1641 1643 1625 1627 <italic xmlns:xlink="http://www.w3.org/1999/xlink">WT</italic>
###xml 1228 1654 1222 1638 <p xmlns:xlink="http://www.w3.org/1999/xlink" textid="41">Phosphorylation of PKB and GSK3&#946;. Myocytes were serum-starved for 12&#160;h prior to incubation with 1&#160;&#956;mol/l insulin for the indicated times. Cell lysates were prepared, and proteins were separated by PAGE followed by western immunoblot analysis for vinculin, total PKB, phospho-PKB (p-PKB S473) and phospho-GSK3&#946; (p-GSK3&#946;) as indicated. This experiment was repeated three times with typical results shown. <italic>WT</italic>, wild-type</p>
###xml 1228 1654 1222 1638 <caption xmlns:xlink="http://www.w3.org/1999/xlink"><p textid="41">Phosphorylation of PKB and GSK3&#946;. Myocytes were serum-starved for 12&#160;h prior to incubation with 1&#160;&#956;mol/l insulin for the indicated times. Cell lysates were prepared, and proteins were separated by PAGE followed by western immunoblot analysis for vinculin, total PKB, phospho-PKB (p-PKB S473) and phospho-GSK3&#946; (p-GSK3&#946;) as indicated. This experiment was repeated three times with typical results shown. <italic>WT</italic>, wild-type</p></caption>
###xml 1654 1654 1638 1638 <graphic xmlns:xlink="http://www.w3.org/1999/xlink" position="anchor" xlink:href="125_2006_531_Fig5_HTML" id="MO5"/>
###xml 1222 1654 1216 1638 <fig xmlns:xlink="http://www.w3.org/1999/xlink" id="Fig5"><label>Fig.&#160;5</label><caption><p textid="41">Phosphorylation of PKB and GSK3&#946;. Myocytes were serum-starved for 12&#160;h prior to incubation with 1&#160;&#956;mol/l insulin for the indicated times. Cell lysates were prepared, and proteins were separated by PAGE followed by western immunoblot analysis for vinculin, total PKB, phospho-PKB (p-PKB S473) and phospho-GSK3&#946; (p-GSK3&#946;) as indicated. This experiment was repeated three times with typical results shown. <italic>WT</italic>, wild-type</p></caption><graphic position="anchor" xlink:href="125_2006_531_Fig5_HTML" id="MO5"/></fig>
As PKB is a key effector kinase that mediates many of the downstream cellular events induced by the PI3K signalling pathway, including insulin-stimulated glucose uptake [26, 27], we determined the phosphorylation status of PKB in wild-type and Pten+/- myocytes. Little to no phosphorylation was observed in the absence of insulin, and phosphorylation at Ser473 was observed upon addition of insulin (Fig. 5). Whereas PKB phosphorylation started to decrease after 4 h in wild-type cells in the presence of insulin, phosphorylation was sustained in Pten+/- cells during the course of the experiment (up to 6 h). Immunoblotting for total PKB protein showed that PKB levels were consistent in Pten+/- and Pten+/+ cells (Fig. 5). Immunoblotting for vinculin was included as a protein-loading control. An immediate downstream substrate of PKB is GSK3beta. This enzyme becomes inactivated upon phosphorylation by PKB, in turn allowing its substrate, glycogen synthase, to mediate glycogen synthesis and thus promote glucose storage. Consistent with the observed enhancement of PKB phosphorylation in Pten+/- cells, these cells also exhibited a higher degree of GSK3beta phosphorylation in comparison with Pten+/+ cells (Fig. 5). Fig. 5Phosphorylation of PKB and GSK3beta. Myocytes were serum-starved for 12 h prior to incubation with 1 mumol/l insulin for the indicated times. Cell lysates were prepared, and proteins were separated by PAGE followed by western immunoblot analysis for vinculin, total PKB, phospho-PKB (p-PKB S473) and phospho-GSK3beta (p-GSK3beta) as indicated. This experiment was repeated three times with typical results shown. WT, wild-type
###end p 40
###begin p 41
###xml 413 415 403 405 <italic xmlns:xlink="http://www.w3.org/1999/xlink">WT</italic>
Phosphorylation of PKB and GSK3beta. Myocytes were serum-starved for 12 h prior to incubation with 1 mumol/l insulin for the indicated times. Cell lysates were prepared, and proteins were separated by PAGE followed by western immunoblot analysis for vinculin, total PKB, phospho-PKB (p-PKB S473) and phospho-GSK3beta (p-GSK3beta) as indicated. This experiment was repeated three times with typical results shown. WT, wild-type
###end p 41
###begin title 42
Discussion
###end title 42
###begin p 43
###xml 53 57 53 57 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Pten</italic>
###xml 268 269 268 269 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="CR9">9</xref>
###xml 270 272 270 272 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="CR11">11</xref>
###xml 486 488 486 488 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="CR28">28</xref>
###xml 391 395 <span type="species:ncbi:10090">mice</span>
Recent studies utilising tissue-specific deletion of Pten in liver, adipose and muscle have shown that these organs make important contributions to the glucose homeostasis of the animal and clearly establish Pten as a negative regulator of insulin signalling in vivo [9-11]. In a separate report, in vivo antisense treatment resulted in 90% reduction of Pten levels in the liver of diabetic mice, normalising blood glucose levels and improving performance in an insulin tolerance test [28]. While the above studies focused on the role of Pten in specific tissues, the current work defines the effects of partial systemic reduction of Pten on the regulation of insulin sensitivity in the context of the whole animal.
###end p 43
###begin p 44
###xml 356 358 352 354 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="CR29">29</xref>
###xml 390 394 386 390 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Pten</italic>
###xml 546 548 542 544 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="CR14">14</xref>
###xml 550 552 546 548 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="CR22">22</xref>
###xml 553 555 549 551 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="CR24">24</xref>
###xml 557 559 553 555 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="CR30">30</xref>
###xml 717 721 713 717 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Pten</italic>
PTEN expression/activity is tightly regulated by a complex mechanism that is currently poorly understood. PTEN is transcriptionally regulated by transcription factors such as p53, Egr-1, NFkappaB and SMADs, while protein levels and activity are modulated by phosphorylation, oxidation, subcellular localisation, phospholipid binding and protein stability [29]. Previous studies showed that Pten haploinsufficiency results in only a 15-50% reduction in Pten protein, leaving a substantial amount of Pten protein remaining in the tissues examined [14, 22-24, 30]. In our hands, western blot analysis indicated similar decreases in tissue Pten levels (data not shown). The present study provides the first evidence that Pten haploinsufficiency leads to insulin hypersensitivity in vivo, suggesting that even small changes in Pten levels or activity can lead to dramatic effects on insulin responses. Thus partial systemic inhibition of PTEN activity may represent a novel strategy to ameliorate the pathology of type 2 diabetes.
###end p 44
###begin p 45
###xml 86 87 86 87 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="CR1">1</xref>
###xml 162 163 162 163 <sub xmlns:xlink="http://www.w3.org/1999/xlink">3</sub>
###xml 165 167 165 167 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="CR31">31</xref>
###xml 169 171 169 171 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="CR32">32</xref>
###xml 468 469 465 466 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="CR9">9</xref>
###xml 470 472 467 469 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="CR11">11</xref>
###xml 474 476 471 473 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="CR28">28</xref>
###xml 513 517 510 514 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Pten</italic>
###xml 517 520 514 517 <sup xmlns:xlink="http://www.w3.org/1999/xlink">+/&#8722;</sup>
###xml 611 612 608 609 <sub xmlns:xlink="http://www.w3.org/1999/xlink">3</sub>
###xml 833 836 830 833 <sup xmlns:xlink="http://www.w3.org/1999/xlink">+/&#8722;</sup>
###xml 1075 1079 1072 1076 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Pten</italic>
###xml 521 525 <span type="species:ncbi:10090">mice</span>
###xml 837 841 <span type="species:ncbi:10090">mice</span>
The PI3K/PKB signalling axis is central to maintenance of normal glucose homeostasis [1]. Pten-deficient cells typically have elevated levels of intracellular PIP3 [31, 32]. The sustained phosphorylation of PKB/Akt and a downstream effector, GSK3beta, observed in the current study is consistent with previous reports of elevated PKB/Akt activation as a result of impaired desensitisation of PI3K-dependent signals under conditions of Pten inactivation or inhibition [9-11, 28]. A subtle reduction of Pten in the Pten+/- mice appears sufficient to achieve a prolonged and robust insulin signal. The roles of PIP3 and PKB/Akt in insulin-mediated glucose uptake have been well-established; therefore, our data collectively suggest that sustained PI3K/PKB/Akt/GSK3 signalling may, in part, contribute to insulin hypersensitivity in Pten+/- mice. However, other PKB/Akt-independent signalling pathways, as well as additional signals delivered by the protein phosphatase and/or adaptor functions of Pten may also contribute to the insulin hypersensitivity phenotype manifested by Pten haploinsufficiency.
###end p 45
###begin p 46
###xml 212 214 212 214 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="CR25">25</xref>
###xml 560 562 560 562 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="CR33">33</xref>
###xml 563 565 563 565 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="CR36">36</xref>
###xml 645 649 645 649 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Pten</italic>
###xml 649 652 649 652 <sup xmlns:xlink="http://www.w3.org/1999/xlink">+/&#8722;</sup>
###xml 930 934 930 934 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Pten</italic>
###xml 934 937 934 937 <sup xmlns:xlink="http://www.w3.org/1999/xlink">+/&#8722;</sup>
###xml 1198 1200 1198 1200 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="CR37">37</xref>
###xml 1292 1293 1292 1293 <sub xmlns:xlink="http://www.w3.org/1999/xlink">3</sub>
###xml 1487 1488 1471 1472 <sub xmlns:xlink="http://www.w3.org/1999/xlink">3</sub>
###xml 1548 1550 1532 1534 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="CR38">38</xref>
###xml 1551 1553 1535 1537 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="CR40">40</xref>
###xml 1673 1675 1649 1651 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="CR38">38</xref>
###xml 1677 1679 1653 1655 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="CR41">41</xref>
###xml 1680 1682 1656 1658 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="CR43">43</xref>
GLUT1 glucose transporters are constitutively present at the cell surface, while GLUT4 cycles between intracellular vesicles and the cell surface in a manner controlled by insulin-mediated signalling mechanisms [25]. In unstimulated fat and muscle cells, the majority of GLUT4 exists in intracellular compartments, while the insulin signal stimulates the exocytosis of GLUT4 to the cell surface. Studies involving PKB/Akt-null animals and silencing of PKB/Akt by RNA interference have demonstrated that PKB/Akt is of primary importance in GLUT4 translocation [33-36]. In the current study, we observed an enhancement of 2-deoxyglucose uptake in Pten+/- cells even in the absence of insulin stimulation, which was consistent with our observation of increased biotinylation of GLUT4 at the cell surface, while GLUT1 levels were unaffected. However, we detected no increase in phosphorylation of PKB/Akt in the absence of insulin in Pten+/- cells. Consistent with these observations, a recent study in which Pten was specifically knocked down by RNA interference reported slight but significant enhancement of deoxyglucose uptake in adipocytes, but no apparent increase in phosphorylation of PKB/Akt [37]. These results could reflect a mechanism(s) affecting glucose transport involving Pten/PIP3 but independent of PKB/Akt. Such a mechanism could involve the atypical protein kinases C-lambda and -zeta (PKC-lambda and PKC-zeta), which, like PKB/Akt, are subject to control by PI3K via PIP3 and 3-phosphoinositide-dependent protein kinase-1 (PDK-1) [38-40]. A number of studies have implicated PKC-lambda/zeta in insulin-stimulated glucose transport and GLUT4 translocation [38, 41-43]. These studies indicate a role for PKC-lambda/zeta which appears to be complementary or parallel to that of PKB/Akt.
###end p 46
###begin p 47
###xml 131 132 131 132 <sub xmlns:xlink="http://www.w3.org/1999/xlink">3</sub>
###xml 300 302 300 302 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="CR44">44</xref>
###xml 322 327 322 327 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Ship2</italic>
###xml 403 405 403 405 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="CR45">45</xref>
###xml 493 499 493 499 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Phox2a</italic>
###xml 578 584 578 584 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Nature</italic>
###xml 705 707 705 707 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="CR46">46</xref>
###xml 826 828 826 828 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="CR46">46</xref>
###xml 830 832 830 832 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="CR47">47</xref>
###xml 969 973 969 973 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Pten</italic>
###xml 333 337 <span type="species:ncbi:10090">mice</span>
###xml 450 454 <span type="species:ncbi:10090">mice</span>
###xml 624 629 <span type="species:ncbi:10090">mouse</span>
###xml 730 735 <span type="species:ncbi:10090">mouse</span>
The importance of the PI3K pathway in insulin signalling has raised interest in developing pharmaceutical antagonists targeting PIP3 phosphatases such as PTEN or Sh2-containing inositol 5'-phosphatase 2 (SHIP2; also known as Inppl1) in an effort to enhance insulin responsiveness in type 2 diabetes [44]. While a study on Ship2-null mice initially implicated Ship2 as a key regulator of glucose uptake [45], it was subsequently recognised that these mice also had deleted a neighbouring gene, Phox2a, which may have contributed to the observed phenotype (corrigendum appears in Nature vol. 431, p. 878). A new gene-targeted mouse has since been generated in which only the gene encoding Ship2 is deleted [46]. Interestingly, this mouse does not exhibit insulin hypersensitivity but is protected against diet-induced obesity, [46, 47]. In the light of these new findings, our observations of dramatic enhancement of insulin sensitivity and glucose uptake resulting from Pten haploinsufficiency suggests that PTEN plays a role in the desensitisation of insulin signalling, and strengthens the hypothesis that PTEN is a key regulator of insulin-stimulated glucose uptake.
###end p 47
###begin p 48
###xml 92 94 92 94 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="CR48">48</xref>
###xml 96 98 96 98 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="CR49">49</xref>
###xml 425 429 425 429 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Pten</italic>
###xml 429 432 429 432 <sup xmlns:xlink="http://www.w3.org/1999/xlink">+/&#8722;</sup>
###xml 894 898 894 898 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Pten</italic>
###xml 956 957 956 957 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="CR9">9</xref>
###xml 1077 1079 1077 1079 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="CR44">44</xref>
###xml 1273 1275 1273 1275 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="CR44">44</xref>
###xml 1660 1662 1660 1662 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="CR12">12</xref>
###xml 1664 1666 1664 1666 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="CR14">14</xref>
###xml 1668 1670 1668 1670 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="CR23">23</xref>
###xml 433 437 <span type="species:ncbi:10090">mice</span>
###xml 909 913 <span type="species:ncbi:10090">mice</span>
Type 2 diabetes is associated with insulin deficiency and resistance to insulin signalling [48, 49]. The current study provides further support for PTEN as a candidate for drug intervention in treating type 2 diabetes. However, enthusiasm for systemic PTEN inhibitors as a therapeutic approach for treating type 2 diabetes is tempered by the potential side-effects of such agents. Most notably, a modest reduction of Pten in Pten+/- mice promotes tumour formation in a wide variety of tissue, suggesting that long-term chronic administration of systemic PTEN inhibitors may lead to enhanced cancer development and progression. Furthermore, the PI3K pathway is an important regulator of numerous normal cellular processes and systemic PTEN inhibition may cause dysfunction of many cells and tissues, leading to alterations in liver, kidney, brain function, etc. For example, hepatocyte-specific Pten-deficient mice exhibit hepatomegaly and liver steatosis [9]. Systemic inhibition of PTEN may therefore be unacceptable clinically because of these inherent potential toxicities [44]. However, targeted delivery of PTEN antagonists to muscle cells or adipocytes may overcome these limitations and they hold promise as clinically viable agents in treatment of type 2 diabetes [44]. This study shows that partial inhibition of Pten is sufficient to enhance insulin sensitivity. This observation is important from a therapeutic standpoint, as most drugs are unlikely to completely inhibit enzyme activity in vivo, nor would complete inhibition be desirable given the potential for cancer development resulting from chronic or overactivation of the PI3K/PKB pathway [12, 14, 23].
###end p 48
###begin p 49
###xml 15 19 15 19 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Pten</italic>
In conclusion, Pten haploinsufficiency results in insulin hypersensitivity, which underscores the importance of PTEN in attenuating insulin signals, and suggests that small-molecule drugs that antagonise PTEN activity may represent a novel class of insulin-sensitising agents and targeted delivery of these agents to muscle cells or adipocytes may have potential clinical utility in treating insulin resistance observed in type 2 diabetes.
###end p 49
###begin title 50
Acknowledgements
###end title 50
###begin p 51
Funding was provided by a grant from Health Canada. J. T. Wong is a recipient of a fellowship from the Canadian Institutes of Health Research. We gratefully acknowledge the assistance of S. McCormick and D. Yapp with microPET, G. Smirnova with immunohistochemistry and Y. Chen for technical assistance. Polyclonal GLUT1 and GLUT4 antibodies were gifts of A. Klip.
###end p 51
###begin p 52
###xml 0 20 0 20 <bold xmlns:xlink="http://www.w3.org/1999/xlink">Duality of interest </bold>
Duality of interest  The authors declare that no duality of interest exists relating to the subject matter of this manuscript.
###end p 52
###begin title 53
References
###end title 53
###begin article-title 54
The insulin signalling pathway
###end article-title 54
###begin article-title 55
The tumor suppressor, PTEN/MMAC1, dephosphorylates the lipid second messenger, phosphatidylinositol 3,4,5-trisphosphate
###end article-title 55
###begin article-title 56
The lipid phosphatase activity of PTEN is critical for its tumor suppressor function
###end article-title 56
###begin article-title 57
###xml 62 67 <span type="species:ncbi:9606">human</span>
PTEN, a putative protein tyrosine phosphatase gene mutated in human brain, breast, and prostate cancer
###end article-title 57
###begin article-title 58
Identification of a candidate tumour suppressor gene, MMAC1, at chromosome 10q23.3 that is mutated in multiple advanced cancers
###end article-title 58
###begin article-title 59
Pten is essential for embryonic development and tumour suppression
###end article-title 59
###begin article-title 60
Disruption of the MMAC1/PTEN gene by deletion or mutation is a frequent event in malignant melanoma
###end article-title 60
###begin article-title 61
PTEN/MMAC1 mutations in endometrial cancers
###end article-title 61
###begin article-title 62
Liver-specific deletion of negative regulator Pten results in fatty liver and insulin hypersensitivity
###end article-title 62
###begin article-title 63
Muscle-specific Pten deletion protects against insulin resistance and diabetes
###end article-title 63
###begin article-title 64
###xml 78 82 <span type="species:ncbi:10090">mice</span>
Insulin hypersensitivity and resistance to streptozotocin-induced diabetes in mice lacking PTEN in adipose tissue
###end article-title 64
###begin article-title 65
###xml 26 30 <span type="species:ncbi:10090">mice</span>
Mutation of Pten/Mmac1 in mice causes neoplasia in multiple organ systems
###end article-title 65
###begin article-title 66
###xml 50 54 <span type="species:ncbi:10090">mice</span>
Impaired Fas response and autoimmunity in Pten+/- mice
###end article-title 66
###begin article-title 67
Haploinsufficiency of the Pten tumor suppressor gene promotes prostate cancer progression
###end article-title 67
###begin article-title 68
###xml 118 121 <span type="species:ncbi:10116">rat</span>
The constitutive secretory pathway is a major route for islet amyloid polypeptide secretion in neonatal but not adult rat islet cells
###end article-title 68
###begin article-title 69
###xml 93 99 <span type="species:ncbi:9557">baboon</span>
Evidence that galanin is a parasympathetic, rather than sympathetic, neurotransmitter in the baboon pancreas
###end article-title 69
###begin article-title 70
Gene delivery to muscle
###end article-title 70
###begin article-title 71
###xml 19 24 <span type="species:ncbi:10090">mouse</span>
Phenotype of adult mouse muscle myoblasts reflects their fiber type of origin
###end article-title 71
###begin article-title 72
###xml 50 55 <span type="species:ncbi:9606">human</span>
Reversible association of cytochalasin B with the human erythrocyte membrane. Inhibition of glucose transport and the stoichiometry of cytochalasin binding
###end article-title 72
###begin article-title 73
###xml 124 132 <span type="species:ncbi:9606">patients</span>
Decreased insulin activation of glycogen synthase in skeletal muscles in young nonobese Caucasian first-degree relatives of patients with non-insulin-dependent diabetes mellitus
###end article-title 73
###begin article-title 74
###xml 35 37 35 37 <sup xmlns:xlink="http://www.w3.org/1999/xlink">18</sup>
Positron-emission tomography with [18F]fluorodeoxyglucose. Part I. Biochemical uptake mechanism and its implication for clinical studies
###end article-title 74
###begin article-title 75
###xml 90 94 <span type="species:ncbi:10090">mice</span>
DNA mismatch repair deficiency accelerates endometrial tumorigenesis in Pten heterozygous mice
###end article-title 75
###begin article-title 76
###xml 55 60 <span type="species:ncbi:10090">mouse</span>
Cooperativity of Nkx3.1 and Pten loss of function in a mouse model of prostate carcinogenesis
###end article-title 76
###begin article-title 77
###xml 88 92 <span type="species:ncbi:10090">mice</span>
An inhibitor of mTOR reduces neoplasia and normalizes p70yS6 kinase activity in Pten+/- mice
###end article-title 77
###begin article-title 78
Turning signals on and off: GLUT4 traffic in the insulin-signaling highway
###end article-title 78
###begin article-title 79
Mechanism of activation of protein kinase B by insulin and IGF-1
###end article-title 79
###begin article-title 80
Unravelling the activation mechanisms of protein kinase B/Akt
###end article-title 80
###begin article-title 81
###xml 74 78 <span type="species:ncbi:10090">mice</span>
Specific inhibition of PTEN expression reverses hyperglycemia in diabetic mice
###end article-title 81
###begin article-title 82
PTEN function: how normal cells control it and tumour cells lose it
###end article-title 82
###begin article-title 83
Pten dose dictates cancer progression in the prostate
###end article-title 83
###begin article-title 84
Negative regulation of PKB/Akt-dependent cell survival by the tumor suppressor PTEN
###end article-title 84
###begin article-title 85
PTEN modulates cell cycle progression and cell survival by regulating phosphatidylinositol 3,4,5,-trisphosphate and Akt/protein kinase B signaling pathway
###end article-title 85
###begin article-title 86
###xml 60 64 <span type="species:ncbi:10090">mice</span>
Insulin resistance and a diabetes mellitus-like syndrome in mice lacking the protein kinase Akt2 (PKB beta)
###end article-title 86
###begin article-title 87
Use of RNA interference-mediated gene silencing and adenoviral overexpression to elucidate the roles of AKT/protein kinase B isoforms in insulin actions
###end article-title 87
###begin article-title 88
Insulin signaling through Akt/protein kinase B analyzed by small interfering RNA-mediated gene silencing
###end article-title 88
###begin article-title 89
Isoform-specific regulation of insulin-dependent glucose uptake by Akt/protein kinase B
###end article-title 89
###begin article-title 90
PTEN, but not SHIP2, suppresses insulin signaling through the phosphatidylinositol 3-kinase/Akt Pathway in 3T3-L1 adipocytes
###end article-title 90
###begin article-title 91
Function and dysfunction of aPKC isoforms for glucose transport in insulin-sensitive and insulin-resistant states
###end article-title 91
###begin article-title 92
Dependence of insulin-stimulated glucose transporter 4 translocation on 3-phosphoinositide-dependent protein kinase-1 and its target threonine-410 in the activation loop of protein kinase C-zeta
###end article-title 92
###begin article-title 93
###xml 185 188 <span type="species:ncbi:10116">rat</span>
Insulin activates protein kinases C-zeta and C-lambda by an autophosphorylation-dependent mechanism and stimulates their translocation to GLUT4 vesicles and other membrane fractions in rat adipocytes
###end article-title 93
###begin article-title 94
Protein kinase C-lambda knockout in embryonic stem cells and adipocytes impairs insulin-stimulated glucose transport
###end article-title 94
###begin article-title 95
###xml 222 225 <span type="species:ncbi:10116">rat</span>
Effects of transiently expressed atypical (zeta, lambda), conventional (alpha, beta) and novel (delta, epsilon) protein kinase C isoforms on insulin-stimulated translocation of epitope-tagged GLUT4 glucose transporters in rat adipocytes : specific interchangeable effects of protein kinases C-zeta and C-lambda
###end article-title 95
###begin article-title 96
Requirement of atypical protein kinase C-lamda for insulin stimulation of glucose uptake but not for Akt activation in 3T3-l1 adipocytes
###end article-title 96
###begin article-title 97
Lipid phosphatases as drug discovery targets for type 2 diabetes
###end article-title 97
###begin article-title 98
The lipid phosphatase SHIP2 controls insulin sensitivity
###end article-title 98
###begin article-title 99
Absence of the lipid phosphatase SHIP2 confers resistance to dietary obesity
###end article-title 99
###begin article-title 100
Staying in SHIP shape
###end article-title 100
###begin article-title 101
Type 2 diabetes: an overview
###end article-title 101
###begin article-title 102
Insulin resistance: current concepts
###end article-title 102
###begin title 103
Abbreviations
###end title 103
###begin p 104
###xml 3 5 3 5 <sup xmlns:xlink="http://www.w3.org/1999/xlink">18</sup>
2-[18F]fluoro-2-deoxyglucose
###end p 104
###begin p 105
glycogen synthase kinase 3
###end p 105
###begin p 106
positron emission tomography
###end p 106
###begin p 107
phosphatidylinositol 3-kinase
###end p 107
###begin p 108
phosphatidylinositol 3,4,5-trisphosphate
###end p 108
###begin p 109
protein kinase B
###end p 109
###begin p 110
phosphatase and tensin homologue
###end p 110
###begin p 111
SH2-containing inositol 5'-phosphatase 2 (also known as INPP5D)
###end p 111

